☰

cached image

Serge Gauthier, MD, FRCPC - Publications

Affiliations: 
Neurology & Neurosurgery, Psychiatry, Medicine McGill University, Montreal, QC, Canada 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=102
Website:
http://aging.mcgill.ca/gauthier.htm
Tree Info Grants Similar researchers PubMed Report error

442/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fernández Arias J, Therriault J, Thomas E, Lussier FZ, Bezgin G, Tissot C, Servaes S, Mathotaarachchi SS, Schoemaker D, Stevenson J, Rahmouni N, Kang MS, Pallen V, Poltronetti NM, Wang YT, ... ... Gauthier S, et al. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer's disease. Brain Communications. 5: fcad146. PMID 37252014 DOI: 10.1093/braincomms/fcad146  0.707
2023 Pascoal TA, Leuzy A, Therriault J, Chamoun M, Lussier F, Tissot C, Strandberg O, Palmqvist S, Stomrud E, Ferreira PCL, Ferrari-Souza JP, Smith R, Benedet AL, Gauthier S, Hansson O, et al. Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12390. PMID 36733847 DOI: 10.1002/dad2.12390  0.305
2022 Jutten RJ, Thompson L, Sikkes SAM, Maruff P, Molinuevo JL, Zetterberg H, Alber J, Faust D, Gauthier S, Gold M, Harrison J, Lee AKW, Snyder PJ. A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. Journal of Alzheimer's Disease : Jad. PMID 35124638 DOI: 10.3233/JAD-215098  0.312
2021 Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9  0.304
2020 Therriault J, Pascoal TA, Benedet AL, Tissot C, Savard M, Chamoun M, Lussier F, Kang MS, Berzgin G, Wang T, Fernandes-Arias J, Massarweh G, Soucy JP, Vitali P, Saha-Chaudhuri P, ... Gauthier S, et al. Frequency of biologically-defined AD in relation to age, sex, APOEε4 and cognitive impairment. Neurology. PMID 33443136 DOI: 10.1212/WNL.0000000000011416  0.301
2020 Paquin V, Therriault J, Pascoal TA, Rosa-Neto P, Gauthier S. Frontal Variant of Alzheimer Disease Differentiated From Frontotemporal Dementia Using in Vivo Amyloid and Tau Imaging. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 33: 288-293. PMID 33264158 DOI: 10.1097/WNN.0000000000000251  0.31
2020 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Schöll M, Zimmer ER, Gauthier S, Labbe A, Zetterberg H, Rosa-Neto P, et al. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease. Brain : a Journal of Neurology. PMID 33210117 DOI: 10.1093/brain/awaa342  0.332
2020 Bateman DR, Gill S, Hu S, Foster ED, Ruthirakuhan MT, Sellek AF, Mortby ME, Matušková V, Ng KP, Tarawneh RM, Freund-Levi Y, Kumar S, Gauthier S, Rosenberg PB, Ferreira de Oliveira F, et al. Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. Alzheimer's & Dementia (New York, N. Y.). 6: e12016. PMID 32995467 DOI: 10.1002/Trc2.12016  0.392
2020 Smith EE, Couillard P, Fisk JD, Ismail Z, Montero-Odasso M, Robillard JM, Vedel I, Sivananthan S, Gauthier S. Pandemic Dementia Scarce Resource Allocation. Canadian Geriatrics Journal : Cgj. 23: 216-218. PMID 32904792 DOI: 10.5770/Cgj.23.457  0.317
2020 Cloutier S, Chertkow H, Kergoat MJ, Gélinas I, Gauthier S, Belleville S. Trajectories of decline on instrumental activities of daily living prior to dementia in persons with mild cognitive impairment. International Journal of Geriatric Psychiatry. PMID 32892375 DOI: 10.1002/Gps.5426  0.368
2020 Gauthier S, Chertkow H, Theriault J, Chayer C, Ménard MC, Lacombe G, Rosa-Neto P, Ismail Z. CCCDTD5: research diagnostic criteria for Alzheimer's Disease. Alzheimer's & Dementia (New York, N. Y.). 6: e12036. PMID 32864413 DOI: 10.1002/Trc2.12036  0.339
2020 Wang HF, Shen XN, Li JQ, Suckling J, Tan CC, Wang YJ, Feng L, Zhang C, Tan L, Dong Q, Touchon J, Gauthier S, Yu JT. Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12095. PMID 32793801 DOI: 10.1002/Dad2.12095  0.413
2020 Therriault J, Benedet A, Pascoal TA, Savard M, Ashton N, Chamoun M, Tissot C, Lussier F, Kang MSP, Bergin G, Wang T, Fernandez-Arias J, Massarweh G, Tissot C, Zetterberg H, ... ... Gauthier S, et al. Determining Amyloid-β positivity using [F]AZD4694 PET imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32737243 DOI: 10.2967/Jnumed.120.245209  0.339
2020 Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, Sivananthan S, Smith EE, Soucy JP, Vedel I, Gauthier S, et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32725777 DOI: 10.1002/Alz.12105  0.401
2020 Pascoal TA, Therriault J, Benedet AL, Savard M, Lussier FZ, Chamoun M, Tissot C, Qureshi MNI, Kang MS, Mathotaarachchi S, Stevenson J, Hopewell R, Massarweh G, Soucy JP, Gauthier S, et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain : a Journal of Neurology. PMID 32671408 DOI: 10.1093/Brain/Awaa180  0.421
2020 Kang MS, Aliaga AA, Shin M, Mathotaarachchi S, Benedet AL, Pascoal TA, Therriault J, Chamoun M, Savard M, Devenyi GA, Mathieu A, Chakravarty MM, Sandelius Å, Blennow K, Zetterberg H, ... ... Gauthier S, et al. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease. Molecular Psychiatry. PMID 32591633 DOI: 10.1038/S41380-020-0818-1  0.418
2020 Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Chamoun M, Tissot C, Lussier F, Mohaddes S, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P. Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12037. PMID 32582834 DOI: 10.1002/Dad2.12037  0.397
2020 Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Schöll M, Massarweh G, Soucy JP, Höglund K, Brinkmalm G, ... ... Gauthier S, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. The Lancet. Neurology. 19: 422-433. PMID 32333900 DOI: 10.1016/S1474-4422(20)30071-5  0.412
2020 Shiells H, Schelter BO, Bentham P, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L, Wischik DJ, Riedel G, Gauthier S, Jia J, et al. Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia. Journal of Alzheimer's Disease : Jad. PMID 32280089 DOI: 10.3233/Jad-191173  0.325
2020 Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Savard M, Chamoun M, Thomas E, Kang MS, Lussier F, Tissot C, Soucy JP, Massarweh G, Rej S, Saha-Chaudhuri P, Poirier J, ... Gauthier S, et al. APOEε4 potentiates the relationship between amyloid-β and tau pathologies. Molecular Psychiatry. PMID 32161362 DOI: 10.1038/S41380-020-0688-6  0.383
2020 Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, Kang MS, Mathotaarachchi S, Benedet AL, Parsons M, Qureshi MNI, Thomas ÉM, Shin M, Dion LA, Massarweh G, ... ... Gauthier S, et al. Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 192-199. PMID 31914223 DOI: 10.1002/Alz.12007  0.422
2019 Wang H, Fan Z, Shi C, Xiong L, Zhang H, Li T, Sun Y, Guo Q, Tian Y, Qu Q, Zhang N, Cheng Z, Wu L, Wu D, Han Z, ... ... Gauthier S, et al. Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project. Journal of Global Health. 9: 020320. PMID 31893029 DOI: 10.7189/Jogh.09.020320  0.38
2019 Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, Thomas E, Kang MS, Lussier F, Tissot C, Parsons M, Qureshi MNI, Vitali P, Massarweh G, Soucy JP, ... ... Gauthier S, et al. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β. Jama Neurology. PMID 31860000 DOI: 10.1001/Jamaneurol.2019.4421  0.336
2019 Ng KP, Chiew HJ, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S. Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Frontiers in Pharmacology. 10: 1398. PMID 31824321 DOI: 10.3389/Fphar.2019.01398  0.408
2019 Ng KP, Therriault J, Kang MS, Struyfs H, Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Massarweh G, Soucy JP, Neto PR, Gauthier S. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [F]THK5351 uptake in progressive supranuclear palsy. Neuroimage. Clinical. 24: 102091. PMID 31795034 DOI: 10.1016/J.Nicl.2019.102091  0.344
2019 Belleville S, LeBlanc AC, Kergoat MJ, Calon F, Gaudreau P, Hébert SS, Hudon C, Leclerc N, Mechawar N, Duchesne S, Gauthier S. The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q). Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 787-796. PMID 31788534 DOI: 10.1016/J.Dadm.2019.07.003  0.392
2019 Benedet AL, Ashton NJ, Pascoal TA, Leuzy A, Mathotaarachchi S, Kang MS, Therriault J, Savard M, Chamoun M, Schöll M, Zimmer ER, Gauthier S, Labbe A, Zetterberg H, Blennow K, et al. Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 679-689. PMID 31673598 DOI: 10.1016/J.Dadm.2019.08.002  0.388
2019 Schelter BO, Shiells H, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L, Riedel G, Gauthier S, Jia J, Bentham P, Kook K, et al. Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31658058 DOI: 10.3233/Jad-190772  0.41
2019 Sharafi SM, Sylvestre JP, Chevrefils C, Soucy JP, Beaulieu S, Pascoal TA, Arbour JD, Rhéaume MA, Robillard A, Chayer C, Rosa-Neto P, Mathotaarachchi SS, Nasreddine ZS, Gauthier S, Lesage F. Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimer's & Dementia (New York, N. Y.). 5: 610-617. PMID 31650017 DOI: 10.1016/J.Trci.2019.09.006  0.332
2019 Ng KP, Richard-Devantoy S, Bertrand JA, Jiang L, Pascoal TA, Mathotaarachchi S, Therriault J, Yatawara C, Kandiah N, Greenwood CMT, Rosa-Neto P, Gauthier S. Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons. International Journal of Geriatric Psychiatry. PMID 31642105 DOI: 10.1002/Gps.5215  0.375
2019 Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, ... ... Gauthier S, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nature Communications. 10: 4227. PMID 31530809 DOI: 10.1038/S41467-019-12242-1  0.373
2019 Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, Tang Y, Qin Q, Wang F, Qiao Y, Shi S, Wang YJ, Du Y, Zhang J, Zhang J, ... ... Gauthier S, et al. Dementia in China: epidemiology, clinical management, and research advances. The Lancet. Neurology. PMID 31494009 DOI: 10.1016/S1474-4422(19)30290-X  0.335
2019 Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, et al. The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-13. PMID 31309917 DOI: 10.1017/Cjn.2019.27  0.383
2019 Cui Y, Dai S, Miao Z, Zhong Y, Liu Y, Liu L, Jing D, Bai Y, Kong Y, Sun W, Li F, Qihao G, Rosa-Neto P, Gauthier S, Wu L. Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31256131 DOI: 10.3233/Jad-190113  0.368
2019 Therriault J, Wang S, Mathotaarachchi S, Pascoal TA, Parent M, Beaudry T, Shin M, Al B, Kang MS, Ng KP, Dansereau C, Park MTM, Fonov V, Carbonell F, Zimmer E, ... ... Gauthier S, et al. Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer's Disease Spectrum. Molecular Neurobiology. PMID 31230260 DOI: 10.1007/S12035-019-01671-0  0.402
2019 Pascoal TA, Mathotaarachchi S, Kang MS, Mohaddes S, Shin M, Park AY, Parent MJ, Benedet AL, Chamoun M, Therriault J, Hwang H, Cuello AC, Misic B, Soucy JP, Aston JAD, ... Gauthier S, et al. Aβ-induced vulnerability propagates via the brain's default mode network. Nature Communications. 10: 2353. PMID 31164641 DOI: 10.1038/S41467-019-10217-W  0.397
2019 Gagnon K, Baril AA, Montplaisir J, Carrier J, De Beaumont L, D'Aragon C, Chami S, Pelleieux S, Poirier J, Gauthier S, Lafond C, Gagnon JF, Gosselin N. Disconnection Between Self-Reported and Objective Cognitive Impairment in Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. PMID 30853044 DOI: 10.5664/Jcsm.7664  0.307
2019 Liu J, Wang Q, Jing D, Gao R, Zhang J, Cui C, Qiao H, Liang Z, Wang C, Rosa-Neto P, Wu L, Jia J, Gauthier S. Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer's Disease with De Novo PSEN1 Mutation. Journal of Alzheimer's Disease : Jad. PMID 30814350 DOI: 10.3233/Jad-181108  0.332
2019 Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, ... ... Gauthier S, et al. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology. PMID 30753379 DOI: 10.1093/Brain/Awz019  0.434
2019 Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Guillo Benarous F, Ulysse A, Oo T, Vedvyas A, Rao JA, Marsh K, Kluger A, Sangha J, Hassan M, ... ... Gauthier S, et al. Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). Journal of Alzheimer's Disease : Jad. 67: 685-705. PMID 30689585 DOI: 10.3233/Jad-180341  0.319
2019 Thorogood A, Mäki-Petäjä-Leinonen A, Dalpé G, Gastmans C, Gauthier S. Openness, inclusion, and respect in dementia research. The Lancet. Neurology. 18: 135-136. PMID 30663603 DOI: 10.1016/S1474-4422(18)30445-9  0.309
2019 Ting SKS, Chen C, Hameed S, Ng A, Kandiah N, Prakash KM, Xie W, Lam WW, Sin GL, Chan LL, Rosa‐Neto P, Gauthier S, Ng KP. Phantom bedside intruder in Parkinson's disease Neurology and Clinical Neuroscience. 7: 91-93. DOI: 10.1111/Ncn3.12258  0.323
2019 Brink SEMvd, Amrani LE, Gauthier S, Rosa-Neto P, Vitali P. P4-532: Clinical Impact Of Csf Assessment On Diagnostic Accuracy In Atypical Dementias In Quebec, Canada: Preliminary Results From A Specialized Dementia Clinic Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.079  0.338
2019 Corriveau-Lecavalier N, Duchesne S, Gauthier S, Hudon C, Kergoat M, Rajah N, Mellah S, Belleville S. P1-391: Evidence For A Quadratic Relation Between Activation And Neurodegeneration In The Prodromal Phase Of Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.996  0.367
2019 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Tissot C, Kunach P, Lussier FZ, Joung MJ, Schöll M, Gauthier S, et al. P1-274: Associations Between Plasma Nfl And Brain Atrophy In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.829  0.359
2019 Ng KP, Cheng GH-, Yatawara C, Rosa-Neto P, Gauthier S, Kandiah N. P1-252: Neurodegeneration Mediates And Moderates The Effect Of Amyloid And Tau On Longitudinal Cognition In Mild Cognitive Impairment Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.807  0.37
2019 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Tissot C, Lussier FZ, Kunach P, Joung MJ, Schöll M, Gauthier S, et al. Ic-P-071: Associations Between Plasma Nfl And Brain Atrophy In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4914  0.348
2019 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Schöll M, Gauthier S, Zetterberg H, Rosa-Neto P, Blennow K. Ic-P-070: Associations Between Plasma Nfl And Brain Pet In The Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4913  0.348
2019 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Schöll M, Gauthier S, Zetterberg H, Rosa-Neto P, Blennow K. F4-05-01: Associations Between Plasma Nfl And Brain Pet In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4729  0.329
2019 Therriault J, Pascoal TA, Savard M, Mathotaarachchi S, Gauthier S, Massarweh G, Rosa-Neto P, Initiative ADN. O3-07-05: Amyloid-Dependent And Amyloid-Independent Effects Of Tau On Clinical Status Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4664  0.3
2019 Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Schöll M, Gauthier S, Zetterberg H, Blennow K, Rosa-Neto P. Ic-P-072: Longitudinal Associations Between Plasma Nfl And Voxel-Based Morphometry In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4554  0.348
2019 Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, Mathotaarachchi S, Kang MS, Benedet AL, Thomas E, Ismail Z, Rosa-Neto P, Gauthier S. O2-11-05: MILD BEHAVIORAL IMPAIRMENT IS ASSOCIATED WITH β-AMYLOID BUT NOT WITH TAU IN COGNITIVELY INTACT ELDERLY INDIVIDUALS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4515  0.339
2019 Therriault J, Pascoal TA, Savard M, Chamoun M, Mathotaarachchi S, Benedet AL, Kang MS, Tissot C, Lussier FZ, Kunach P, Qureshi MNI, Thomas E, Massarweh G, Gauthier S, Rosa-Neto P. Amyloid-Dependent And Amyloid-Independent Effects Of Tau On Clinical Status Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4297  0.324
2019 Stevenson J, Chamoun M, Pascoal TA, Benedet AL, Kang MS, Mathotaarachchi S, Therriault J, Thomas E, Savard M, Tissot C, Kunach P, Lussier FZ, Gauthier S, Rosa-Neto P. Ic-P-146: The Translational Biomarkers In Aging And Dementia: Triad, A Biomarker Oriented Cohort Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3999  0.303
2019 Mathotaarachchi S, Pascoal TA, Benedet AL, Chamoun M, Kang MS, Therriault J, Savard M, Lussier FZ, Tissot C, Thomas E, Fonov VS, Gauthier S, Rosa-Neto P. Ic-P-170: Subthreshold Level Tau Deposition Occurs Prior To Subthreshold Amyloid Deposition In Cognitively Normal Elderly Individuals Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3997  0.337
2019 Thomas E, Therriault J, Pascoal TA, Mathotaarachchi S, Savard M, Chamoun M, Kang MS, Gauthier S, Rosa-Neto P. P3-481: Emotional Modulation Of Memory Across The Alzheimer'S Disease Spectrum And Association With Grey Matter Density Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3516  0.342
2019 Tissot C, Benedet AL, Pascoal TA, Mathotaarachchi S, Savard M, Therriault J, Kang MS, Chamoun M, Leuzy A, Schöll M, Ashton NJ, Gauthier S, Zetterberg H, Blennow K, Rosa-Neto P. P3-257: Association Of Plasma Neurofilament Light And White Matter Density In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3288  0.327
2019 Tissot C, Pascoal TA, Therriault J, Chamoun M, Lussier FZ, Savard M, Mathotaarachchi S, Benedet AL, Thomas E, Rosa-Neto P, Gauthier S. P2-473: Neuropsychiatric Symptoms Relate To Tau But Not Amyloid In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2880  0.394
2019 Wachtelaer E, Savard M, Rudko D, Kang MS, Pascoal TA, Mathotaarachchi S, Therriault J, Chamoun M, Benedet AL, Thomas E, Tissot C, Lussier FZ, Parson M, Gauthier S, Rosa-Neto P. Ic-P-132: Cortical Iron Deposition In Alzheimer'S Disease Contrasts With Age-Related Subcortical Deposition Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2810  0.325
2019 Qureshi MNI, Gauthier S, Rosa-Neto P, Mathotaarachchi S, Benedet AL, Chamoun M, Kang MS, Therriault J, Pascoal TA, Thomas E, Kunach P, Tissot C, Lussier FZ, Savard M. P2-346: Tau And Amyloid Pathology Suppress Global Brain Functional Connectivity Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2753  0.321
2018 Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P. Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia. Molecular Neurobiology. PMID 30414086 DOI: 10.1007/S12035-018-1405-1  0.398
2018 Zhang H, Ng KP, Therriault J, Kang MS, Pascoal TA, Rosa-Neto P, Gauthier S. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease. Translational Neurodegeneration. 7: 23. PMID 30311914 DOI: 10.1186/S40035-018-0127-7  0.41
2018 Ng KP, Chiew HJ, Lim L, Rosa-Neto P, Kandiah N, Gauthier S. The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia. Expert Review of Neurotherapeutics. PMID 30286681 DOI: 10.1080/14737175.2018.1532792  0.339
2018 Gagnon K, Baril AA, Montplaisir J, Carrier J, Chami S, Gauthier S, Lafond C, Gagnon JF, Gosselin N. Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnea. The European Respiratory Journal. PMID 30190270 DOI: 10.1183/13993003.01137-2018  0.32
2018 Zhang H, Therriault J, Kang MS, Ng KP, Pascoal TA, Rosa-Neto P, Gauthier S. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Alzheimer's Research & Therapy. 10: 80. PMID 30115118 DOI: 10.1186/S13195-018-0407-6  0.43
2018 Gauthier S, Herrmann N, Rosa-Neto P. Optimal use of cholinergic drugs in Alzheimer's disease. Brain : a Journal of Neurology. PMID 30084978 DOI: 10.1093/Brain/Awy204  0.344
2018 Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, Bennacef I, Therriault J, Ng KP, Hopewell R, Bouhachi R, Hsiao HH, Benedet AL, Soucy JP, Massarweh G, ... Gauthier S, et al. In vivo quantification of neurofibrillary tangles with [F]MK-6240. Alzheimer's Research & Therapy. 10: 74. PMID 30064520 DOI: 10.1186/S13195-018-0402-Y  0.343
2018 Gauthier S, Zhang H, Ng KP, Pascoal TA, Rosa-Neto P. Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? Translational Neurodegeneration. 7: 12. PMID 29876101 DOI: 10.1186/S40035-018-0117-9  0.401
2018 Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29842864 DOI: 10.1016/J.Jalz.2018.05.002  0.383
2018 Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P. Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment. Journal of Alzheimer's Disease : Jad. PMID 29504543 DOI: 10.3233/Jad-179924  0.373
2018 Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. Jama Neurology. PMID 29482212 DOI: 10.1001/Jamaneurol.2017.5135  0.384
2018 Schoemaker D, Buss C, Head K, Sandman CA, Davis EP, Chakravarty MM, Gauthier S, Pruessner JC. Corrigendum to "Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation"[NeuroImage 129 (2016) 1-14]. Neuroimage. 173: 1-2. PMID 29477029 DOI: 10.1016/J.Neuroimage.2018.02.009  0.708
2018 Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P. variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurology. Genetics. 4: e216. PMID 29473050 DOI: 10.1212/Nxg.0000000000000216  0.395
2018 Mortby ME, Black SE, Gauthier S, Miller D, Porsteinsson A, Smith EE, Ismail Z. Dementia clinical trial implications of mild behavioral impairment. International Psychogeriatrics. 30: 171-175. PMID 29448970 DOI: 10.1017/S1041610218000042  0.379
2018 Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology. PMID 29444971 DOI: 10.1212/Wnl.0000000000005120  0.35
2018 Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han Y, Han Y, ... ... Gauthier S, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29433981 DOI: 10.1016/J.Jalz.2017.12.006  0.341
2018 Pascoal TA, Mathotaarachchi S, Shin M, Park AY, Mohades S, Benedet AL, Kang MS, Massarweh G, Soucy JP, Gauthier S, Rosa-Neto P. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29396637 DOI: 10.1007/S00259-018-3933-3  0.44
2018 Belleville S, Hudon C, Bier N, Brodeur C, Gilbert B, Grenier S, Ouellet MC, Viscogliosi C, Gauthier S. MEMO+: Efficacy, Durability and Effect of Cognitive Training and Psychosocial Intervention in Individuals with Mild Cognitive Impairment. Journal of the American Geriatrics Society. PMID 29313875 DOI: 10.1111/Jgs.15192  0.323
2018 Li X, Ba M, Ng KP, Mathotaarachchi S, Pascoal TA, Rosa-Neto P, Gauthier S. Characterizing biomarker features of cognitively normal individuals with ventriculomegaly. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 12-21. PMID 29159265 DOI: 10.1016/J.Dadm.2017.08.001  0.329
2018 Therriault J, Pascoal TA, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Savard M, Chamoun M, Soucy J, Gauthier S, Rosa-Neto P. P1-486: Lateral Temporal Amyloid Load Predicts The Progression To Alzheimer'S Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.496  0.382
2018 Pascoal TA, Chamoun M, Benedet AL, Shin M, Mathotaarachchi S, Kang M, Therriault J, Savard M, Thomas E, Massarweh G, Soucy J, Gauthier S, Rosa-Neto P. P1-482: Association Of [18F]Mk6240 Pet Tau Binding With Clinical Diagnosis, Apoe4, Cognition, Amyloid, Age, And Braak Stages Across The Ad Clinical Spectrum Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.492  0.384
2018 Pascoal TA, Shin M, Chamoun M, Mathotaarachchi S, Kang MS, Therriault J, Savard M, Chakravarty M, Massarweh G, Thomas E, Soucy J, Gauthier S, Rosa-Neto P. O3-10-06: Brain Epigenetic Changes Measured With The Novel [11C]Martinostat Pet Mediate The Effects Of Amyloid And Tau Pet Deposition On Cognition Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2830  0.316
2018 Pascoal TA, Chamoun M, Kang MS, Shin M, Mathotaarachchi S, Therriault J, Savard M, Benedet AL, Thomas E, Massarweh G, Soucy J, Gauthier S, Rosa-Neto P. Ic-P-213: [18F]Mk6240 Pet Tau Binding In Atypical Ad And Non-Ad Tauopathies Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2280  0.345
2018 Chamoun M, Kang MS, Pascoal TA, Mathotaarachchi S, Benedet AL, Shin M, Therriault J, Bouhachi R, Hsiao C, Massarweh G, Chartrand D, Soucy J, Gauthier S, Rosa-Neto P. Ic-P-208: Correlation Between Csf T-Tau And P-Tau With [18F]Mk6240 In The Diagnosis Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2275  0.352
2018 Mathotaarachchi S, Pascoal TA, Benedet AL, Kang MS, Chamoun M, Therriault J, Savard M, Thomas E, Shin M, Fonov VS, Soucy J, Gauthier S, Rosa-Neto P. Ic-P-103: Logical Memory Deficits Across Alzheimer'S Disease Spectrum Are Associated With Patterns Of Tau Propagation Predicted By Braak Staging Alzheimers & Dementia. 14: 89. DOI: 10.1016/J.Jalz.2018.06.2169  0.361
2018 Kang MS, Mathotaarachchi S, Pascoal TA, Benedet AL, Chamoun M, Savard M, Therriault J, Shin M, Thomas E, Soucy J, Massarweh G, Gauthier S, Rosa-Neto P. Ic-P-055: Regional Patterns Of Tau Deposition Driven By Local Amyloid Accumulation Recapitulate Braak Stages In Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2120  0.328
2018 Therriault J, Pascoal TA, Mathotaarachchi S, Kang MS, Shin M, Chamoun M, Benedet AL, Savard M, Thomas E, Gauthier S, Rosa-Neto P. Ic-P-022: Lateral Temporal Amyloid Load Predicts Progression To Alzheimer'S Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2086  0.369
2018 Pascoal TA, Chamoun M, Shin M, Benedet AL, Mathotaarachchi S, Kang MS, Therriault J, Savard M, Thomas E, Massarweh G, Soucy J, Gauthier S, Rosa-Neto P. Ic-04-05: Imaging Epigenetics In The Human Brain With The Novel [11C]Martinostat Pet In Preclinical Ad, Mci, Ad, And Frontotemporal Dementia Individuals Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2053  0.373
2018 Kang MS, Shin M, Mathotaarachchi S, Pascoal TA, Parent MJ, Benedet AL, Therriault J, Chamoun M, Savard M, Thomas E, Aliaga A, Massarweh G, Soucy J, Gauthier S, Cuello AC, et al. Ic-P-054: Amyloid And Microglial Activation Synergy Leads To Hypometabolism In The Ad Brain: Micropet Longitudinal Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1699  0.347
2018 Benedet AL, Pascoal TA, Chamoun M, Savard M, Schoemaker D, Mathotaarachchi S, Kang M, Therriault J, Collins L, Gauthier S, Poirier J, Labbe A, Rosa-Neto P. Ic-P-064: The Impact Of Tspo Rs6971 Polymorphism In A Canadian Neuroimaging Study Of Neuroinflammation Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1044  0.643
2017 Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P. Comparative effect of statins on the risk of incident Alzheimer disease. Neurology. PMID 29247073 DOI: 10.1212/Wnl.0000000000004818  0.379
2017 Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, Davis CS, Staff RT, Vuksanovic V, Ahearn T, Bracoud L, et al. Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 29154277 DOI: 10.3233/Jad-170560  0.375
2017 Parent MJ, Zimmer ER, Shin M, Kang MS, Fonov VS, Mathieu A, Aliaga A, Kostikov A, Do Carmo S, Dea D, Poirier J, Soucy JP, Gauthier S, Cuello AC, Rosa-Neto P. Multimodal imaging in rat model recapitulates Alzheimer's Disease biomarkers abnormalities. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29097597 DOI: 10.1523/Jneurosci.1346-17.2017  0.434
2017 Gauthier S, Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedetti AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P. Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology. 89: 1931. PMID 29084927 DOI: 10.1212/Wnl.0000000000004593  0.382
2017 Ba M, Li X, Ng KP, Pascoal TA, Mathotaarachchi S, Rosa-Neto P, Gauthier S. The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database. Alzheimer's & Dementia (New York, N. Y.). 3: 107-113. PMID 29067322 DOI: 10.1016/J.Trci.2016.12.005  0.408
2017 Schoemaker D, Poirier J, Collins DL, Gauthier S, Pruessner JC. Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 21-24. PMID 28761928 DOI: 10.1016/J.Dadm.2017.05.008  0.775
2017 Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Rosa-Neto P. Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiology of Aging. PMID 28756942 DOI: 10.1016/J.Neurobiolaging.2017.06.027  0.409
2017 Lajoie I, Nugent S, Debacker C, Dyson K, Tancredi FB, Badhwar A, Belleville S, Deschaintre Y, Bellec P, Doyon J, Bocti C, Gauthier S, Arnold D, Kergoat MJ, Chertkow H, et al. Application of calibrated fMRI in Alzheimer's disease. Neuroimage. Clinical. 15: 348-358. PMID 28560160 DOI: 10.1016/J.Nicl.2017.05.009  0.405
2017 Brayet P, Petit D, Baril AA, Gosselin N, Gagnon JF, Soucy JP, Gauthier S, Kergoat MJ, Carrier J, Rouleau I, Montplaisir J. Brain perfusion during rapid-eye-movement sleep successfully identifies amnestic mild cognitive impairment. Sleep Medicine. 34: 134-140. PMID 28522082 DOI: 10.1016/J.Sleep.2017.01.025  0.32
2017 Müller WE, Eckert A, Eckert GP, Fink H, Friedland K, Gauthier S, Hoerr R, Ihl R, Kasper S, Möller HJ. Therapeutic efficacy of the Ginkgo special extract EGb761(®) within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-17. PMID 28460580 DOI: 10.1080/15622975.2017.1308552  0.379
2017 Rajah MN, Wallace LMK, Ankudowich E, Yu EH, Swierkot A, Patel R, Chakravarty MM, Naumova D, Pruessner J, Joober R, Gauthier S, Pasvanis S. Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife. Neuroimage. Clinical. 14: 760-774. PMID 28413778 DOI: 10.1016/J.Nicl.2017.03.016  0.574
2017 Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedet AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P, Gauthier S. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology. PMID 28404803 DOI: 10.1212/Wnl.0000000000003916  0.387
2017 Schoemaker D, Mascret C, Collins DL, Yu E, Gauthier S, Pruessner JC. Recollection and familiarity in aging individuals: Gaining insight into relationships with medial temporal lobe structural integrity. Hippocampus. PMID 28281326 DOI: 10.1002/Hipo.22725  0.72
2017 Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28238739 DOI: 10.1016/J.Jalz.2017.01.007  0.455
2017 Bergeron D, Flynn K, Verret L, Poulin S, Bouchard RW, Bocti C, Fülöp T, Lacombe G, Gauthier S, Nasreddine Z, Jr Laforce R. Multicenter Validation of an MMSE-MoCA Conversion Table. Journal of the American Geriatrics Society. PMID 28205215 DOI: 10.1111/Jgs.14779  0.425
2017 Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctôt KL, Miller DS, Mortby ME, Onyike CU, Rosenberg PB, et al. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. Journal of Alzheimer's Disease : Jad. PMID 28059789 DOI: 10.3233/Jad-160979  0.387
2017 Struyfs H, Pascoal TA, Ng KP, Mathotaarachchi SS, Benedet AL, Kang MS, Shin M, Therriault J, Billiet T, Smeets D, Ribbens A, Gauthier S, Bjerke M, Engelborghs S, Rosa-Neto P. The “A/T/N” System: Added Predictive Value Of N Biomarkers Of Progression From Mci To Dementia Over 2 And 4 Years Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.685  0.344
2017 Schoemaker D, Gauthier S, Poirier J, Pruessner JC. [P1-496]: FAMILIARITY DEFICITS IN INDIVIDUALS WITH APOE E4: AN MRI INVESTIGATION OF STRUCTURAL CORRELATES Alzheimer's & Dementia. 13: P480-P481. DOI: 10.1016/J.Jalz.2017.06.512  0.718
2017 Pascoal TA, Mathotaarachchi SS, Kang MS, Shin M, Benedet AL, Soucy J, Cuello C, Gauthier S, Rosa-Neto P, Struyfs H, Ng KP, Therriault J. Combined Global And Regional Amyloid Effect On The Default Mode Network Leads To Cognitive Decline Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.468  0.309
2017 Therriault J, Ng KP, Pascoal TA, Kang MS, Mathotaarachchi SS, Struyfs H, Shin M, Gauthier S, Nair V, Rosa-Neto P. Lack Of Self-Awareness Of Cognitive Deficits Predicts Default Mode Network Metabolic Decline In Mild Cognitive Impairment Alzheimers & Dementia. 13: 401. DOI: 10.1016/J.Jalz.2017.06.384  0.309
2017 Therriault J, Pascoal TA, Ng KP, Mathotaarachchi SS, Kang MS, Shin M, Struyfs H, Gauthier S, Nair V, Rosa-Neto P. Lack Of Self-Awareness Of Cognitive Deficits In Alzheimer’S Disease Is Related To Decreased Metabolism In The Posterior Cingulate Cortex Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2423  0.328
2017 Therriault J, Ng KP, Pascoal TA, Mathotaarachchi SS, Kang MS, Shin M, Gauthier S, Nair V, Rosa-Neto P. Lack Of Self-Awareness Of Cognitive Deficits Predicts Metabolic Decline In Mild Cognitive Impairment Alzheimers & Dementia. 13: 112. DOI: 10.1016/J.Jalz.2017.06.2422  0.317
2017 Cloutier S, Chertkow H, Kergoat M, Gauthier S, Belleville S. Natural History Of The Decline In Instrumental Activities Of Daily Living Prior To Dementia In Persons With Mild Cognitive Impairment Alzheimers & Dementia. 13: 1136. DOI: 10.1016/J.Jalz.2017.06.1654  0.359
2017 Pascoal TA, Mathotaarachchi SS, Shin M, Benedet AL, Kang MS, Ng KP, Struyfs H, Therriault J, Soucy J, Gauthier S, Rosa-Neto P. Pet Tau And Amyloid Synergism Within The Default Mode Network Determines The Clinical Status In The Predementia Phase Of Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1629  0.311
2017 Abushakra S, Sadowsky CH, Porsteinsson AP, Gauthier S, Vellas B, Power A, Shen L, Wang P, Hey J, Tolar M. Clinical Effects Of Tramiprosate In Apoe4 Homozygotes With Mild To Moderate Alzheimer'S Disease (Ad) Are Sustained Over 130 Weeks: Results Of A Phase 3 Extension Study Alzheimers & Dementia. 13: 256. DOI: 10.1016/J.Jalz.2017.06.119  0.424
2016 Schilling LP, Zimmer ER, Shin M, Leuzy A, Pascoal TA, Benedet AL, Borelli WV, Palmini A, Gauthier S, Rosa-Neto P. Imaging Alzheimer's disease pathophysiology with PET. Dementia & Neuropsychologia. 10: 79-90. PMID 29213438 DOI: 10.1590/S1980-5764-2016Dn1002003  0.426
2016 Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Mohades S, Wang S, Beaudry T, Kang MS, Soucy JP, Labbe A, Gauthier S, Rosa-Neto P. Synergistic interaction between amyloid and tau predicts the progression to dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28024995 DOI: 10.1016/J.Jalz.2016.11.005  0.392
2016 Gauthier S. Research update on Alzheimer's disease and introduction to the Expert Review of Neurotherapeutics special issue. Expert Review of Neurotherapeutics. PMID 27911115 DOI: 10.1080/14737175.2017.1268054  0.354
2016 Ba M, Kong M, Li X, Ng KP, Rosa-Neto P, Gauthier S. Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease? Translational Neurodegeneration. 5: 20. PMID 27891223 DOI: 10.1186/S40035-016-0067-Z  0.401
2016 Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet (London, England). PMID 27863809 DOI: 10.1016/S0140-6736(16)31275-2  0.391
2016 Schoemaker D, Poirier J, Escobar S, Gauthier S, Pruessner J. Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 132-9. PMID 27239534 DOI: 10.1016/J.Dadm.2015.11.007  0.782
2016 Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, ... ... Gauthier S, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 292-323. PMID 27012484 DOI: 10.1016/J.Jalz.2016.02.002  0.382
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.414
2016 Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Alzheimer's Disease : Jad. PMID 26967214 DOI: 10.3233/Jad-150978  0.359
2016 Laforce R, Rosa-Neto P, Soucy JP, Rabinovici GD, Dubois B, Gauthier S. Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-10. PMID 26916179 DOI: 10.1017/Cjn.2015.401  0.363
2016 Schoemaker D, Buss C, Head K, Sandman CA, Davis EP, Chakravarty MM, Gauthier S, Pruessner J. Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation. Neuroimage. PMID 26824403 DOI: 10.1016/J.Neuroimage.2016.01.038  0.71
2016 Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Stern Y, Rentz DM. Dependence Levels As Interim Clinical Milestones Along The Continuum Of Alzheimer’S Disease (Ad): 18-Month Results From The Geras Observational Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.744  0.384
2016 Gauthier S, Feldman HH, Schneider LS, Wilcock G, Frisoni GB, Hardlund J, Kook K, Wischik DJ, Schelter BO, Storey JM, Harrington CR, Wischik CM. O4-08-02: Phase 3 Trial of the TAU Aggregation Inhibitor Leuco-Methylthioninium-Bis (Hydromethanesulfonate) (Lmtm) in Mild to Moderate Alzheimer's Disease Alzheimer's & Dementia. 12: P351-P352. DOI: 10.1016/J.Jalz.2016.06.650  0.349
2016 Boller B, Ouellet É, Mellah S, Gauthier S, Belleville S. O3-05-05: Cognitive Reserve Modulates Encoding-Related Neural Response after Memory Training in Individuals with Subjective Cognitive Decline Alzheimer's & Dementia. 12: P297-P297. DOI: 10.1016/J.Jalz.2016.06.535  0.304
2016 Schoemaker D, Gauthier S, Pruessner JC. P3-320: False Alarms, Recollection, Familiarity, and Confidence in Recognition Memory in Healthy Elderly Individuals: Associations with Hippocampal Volumes Alzheimer's & Dementia. 12: P966-P966. DOI: 10.1016/J.Jalz.2016.06.1984  0.719
2016 Mathotaarachchi SS, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Labbe A, Rosa-Neto P. Voxel-Wise Logistic Regression Improves Prediction Accuracy For Developing Ad Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.190  0.31
2016 Kang MS, Mathotaarachchi SS, Parent MJ, Zimmer ER, Pascoal TA, Shin M, Benedet AL, Aliaga A, Carmo SD, Soucy J, Gauthier S, Cuello AC, Rosa-Neto P. Synergism Between Baseline Amyloidosis And Neuronal Injury As Determinants Of Learning Deficits In Alzheimer'S Disease Transgenic Rat Model Alzheimers & Dementia. 12: 910. DOI: 10.1016/J.Jalz.2016.06.1883  0.314
2016 Pascoal TA, Mathotaarachchi SS, Benedet AL, Shin M, Kang MS, Mohades S, Beaudry T, Soucy J, Gauthier S, Rosa-Neto P. Cognitive Decline Is Driven By The Regional Synergism Between Amyloid Load And Hypometabolism In Mild Cognitive Impairment Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.117  0.342
2016 Pascoal TA, Mathotaarachchi SS, Benedet AL, Shin M, Wang S, Kang MS, Mohades S, Beaudry T, Labbe A, Soucy J, Gauthier S, Rosa-Neto P. Amyloid-B And Hyperphosphorylated Tau Synergy Drives Clinical Progression To Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.115  0.346
2016 Mathotaarachchi SS, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Labbe A, Rosa-Neto P. Voxel-Wise Logistic Regression Improves Prediction Accuracy For Developing Alzheimer'S Disease Alzheimers & Dementia. 12: 527. DOI: 10.1016/J.Jalz.2016.06.1032  0.363
2016 Shin M, Mathotaarachchi SS, Parent MJ, Kang MS, Zimmer ER, Pascoal TA, Carmo SD, Soucy J, Gauthier S, Cuello AC, Rosa-Neto P. Amyloid-Induced Microglial Activity In Thalamocortical Circuits Predicts Subsequent Cognitive Decline Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.037  0.323
2015 Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. "Why therapy development for dementia has failed in the last two decades?" Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26710325 DOI: 10.1016/J.Jalz.2015.12.003  0.312
2015 Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A, Beaudry T, Picard C, Gauthier S, Poirier J, Rouleau G, et al. Epistasis analysis links immune cascades and cerebral amyloidosis. Journal of Neuroinflammation. 12: 227. PMID 26626881 DOI: 10.1186/S12974-015-0436-Z  0.356
2015 Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T. Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study. Journal of Alzheimer's Disease : Jad. 48: 473-81. PMID 26402011 DOI: 10.3233/Jad-150414  0.352
2015 Cloutier S, Chertkow H, Kergoat MJ, Gauthier S, Belleville S. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 47: 901-13. PMID 26401770 DOI: 10.1016/J.Jalz.2014.04.194  0.412
2015 Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26079412 DOI: 10.1016/J.Jalz.2015.04.008  0.381
2015 Gauthier S, Proaño JV, Jia J, Froelich L, Vester JC, Doppler E. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Dementia and Geriatric Cognitive Disorders. 39: 332-47. PMID 25832905 DOI: 10.1016/J.Jalz.2014.05.1709  0.42
2015 Leuzy A, Zimmer ER, Dubois J, Pruessner J, Cooperman C, Soucy JP, Kostikov A, Schirmaccher E, Désautels R, Gauthier S, Rosa-Neto P. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD. Brain Structure & Function. PMID 25596865 DOI: 10.1007/S00429-014-0978-3  0.512
2015 Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage É, Ouellet MC, Viscogliosi C, Belleville S. Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study. International Psychogeriatrics / Ipa. 27: 511-25. PMID 25268968 DOI: 10.1017/S1041610214001902  0.322
2015 Pascoal TA, Mohades S, Mathotaarachchi SS, Benedet AL, Shin M, Manitsirikul S, Wang S, Beaudry T, Fonov V, Labbe A, Gauthier S, Rosa-Neto P. Baseline CSF p-tau and fibrillary amyloid load predict mesial temporal hypometabolism in 24-months follow-up in cognitively normal subjects Alzheimers & Dementia. 11: 104. DOI: 10.1016/J.Jalz.2015.07.450  0.346
2015 Vitali P, Gauthier S, Beaudry T, Soucy J, Brambati SM, Rosa-Neto P. Extensive white matter burden represents a new radiological phenotype in a distinct population of ad patients Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.376  0.316
2014 Gauthier S, Schlaefke S. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clinical Interventions in Aging. 9: 2065-77. PMID 25506211 DOI: 10.2147/Cia.S72728  0.319
2014 Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P. Developments in Tau PET Imaging. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 41: 547-53. PMID 25424608 DOI: 10.1017/Cjn.2014.15  0.346
2014 Zimmer ER, Parent MJ, Cuello AC, Gauthier S, Rosa-Neto P. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research. Trends in Neurosciences. 37: 629-41. PMID 25151336 DOI: 10.1016/J.Tins.2014.07.002  0.394
2014 Schoemaker D, Gauthier S, Pruessner JC. Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review. Neuropsychology Review. 24: 313-31. PMID 25115809 DOI: 10.1007/S11065-014-9265-6  0.78
2014 Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, ... ... Gauthier S, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 799-807.e2. PMID 25012867 DOI: 10.1016/J.Jalz.2014.05.1749  0.426
2014 Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P. Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. Journal of Neuroinflammation. 11: 120. PMID 25005532 DOI: 10.1186/1742-2094-11-120  0.418
2014 Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S. Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 21: 143-8. PMID 24919109 DOI: 10.3109/13506129.2014.926267  0.39
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.429
2014 Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, et al. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty. Frontiers in Aging Neuroscience. 6: 54. PMID 24715864 DOI: 10.3389/Fnagi.2014.00054  0.337
2014 Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Translational Neurodegeneration. 3: 6. PMID 24628994 DOI: 10.1186/2047-9158-3-6  0.375
2014 Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine. 275: 304-16. PMID 24605810 DOI: 10.1111/Joim.12167  0.384
2014 Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. Journal of Internal Medicine. 275: 214-28. PMID 24605806 DOI: 10.1111/Joim.12190  0.359
2014 Belleville S, Gauthier S, Lepage E, Kergoat MJ, Gilbert B. Predicting decline in mild cognitive impairment: a prospective cognitive study. Neuropsychology. 28: 643-52. PMID 24588699 DOI: 10.1037/Neu0000063  0.33
2014 Wu L, Soder RB, Schoemaker D, Carbonnell F, Sziklas V, Rowley J, Mohades S, Fonov V, Bellec P, Dagher A, Shmuel A, Jia J, Gauthier S, Rosa-Neto P. Resting state executive control network adaptations in amnestic mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 40: 993-1004. PMID 24583406 DOI: 10.1016/J.Jalz.2013.05.831  0.687
2014 Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S. Imaging biomarkers for amyloid: a new generation of probes and what lies ahead. International Psychogeriatrics / Ipa. 26: 703-7. PMID 24524685 DOI: 10.1017/S1041610214000118  0.399
2014 Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 439-47. PMID 24418053 DOI: 10.1016/J.Jalz.2013.09.008  0.34
2014 Gauthier S, Leuzy A, Rosa-Neto P. How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease? Neuro-Degenerative Diseases. 13: 197-9. PMID 23942173 DOI: 10.1159/000353748  0.45
2014 Leuzy A, Zimmer ER, Gauthier S, Rosa-Neto P. Amyloid imaging in Alzheimer's disease: A potential new era of personalized medicine? Translational Neuroscience. 5: 51-56. DOI: 10.2478/S13380-014-0205-Y  0.414
2014 Schilling LP, Leuzy A, Zimmer ER, Gauthier S, Rosa-Neto P. Nonamyloid PET biomarkers and alzheimer's disease: Current and future perspectives Future Neurology. 9: 597-613. DOI: 10.2217/Fnl.14.40  0.448
2014 Gauthier S. How aggressive should prevention treatments be against Alzheimer's disease? Neurobiology of Aging. 35: S8. DOI: 10.1016/J.Neurobiolaging.2014.01.060  0.385
2014 Gauthier S, Johnson K, Dubois B. Communicating the diagnosis of Alzheimer's disease: Dilemmas and perspectives Neurobiology of Aging. 35: S8. DOI: 10.1016/J.Neurobiolaging.2014.01.059  0.35
2014 Gault LM, Meier A, Florian H, Gauthier S, Lin Y, Tang Q, Othman A. A Phase 2 Trial Of The Efficacy And Safety Of The Alpha7 Agonist Abt-126 As An Add-On Treatment In Mild-To-Moderate Alzheimer'S Dementia Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.123  0.322
2014 Beaudry T, Lafaille-Magnan M, Rowley J, Schilling LP, Mohades S, Farajat D, Shin M, Gauthier S, Rosa-Neto P. Parietal White Matter Tract Alterations In Mci And Alzheimer'S Disease Patients From The Adni Dataset Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.073  0.403
2014 Shin M, Parent M, Zimmer ER, Kang MS, Mathieu A, Wang S, Allard S, Carmo SD, Gauthier S, Cuello C, Rosa-Neto P. Hippocampal Atrophy In The Mcgill-R-Thy1-App Rat Model Of Alzheimer'S Disease: A Follow Up Study Alzheimers & Dementia. 10: 477. DOI: 10.1016/J.Jalz.2014.05.692  0.351
2014 Leuzy A, Zimmer ER, Aliaga A, Schilling LP, Guiot M, Schirrmacher ES, Soucy J, Gauthier S, Rosa-Neto P. In Vitro Quantification Of Tau Pathology In Alzheimer'S Disease: An [18F]T807 Autoradiographic Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.224  0.358
2014 Schoemaker D, Near J, Gauthier S, Pruessner J. IC-P-164: GLUTAMATERGIC CONCENTRATION AS A BIOMARKER OF MEMORY PERFORMANCE IN AGING INDIVIDUALS Alzheimer's & Dementia. 10: P92-P92. DOI: 10.1016/J.Jalz.2014.05.171  0.746
2014 Belleville S, LeBlanc AC, Duchesne S, Gaudreau P, Gauthier S, Hudon C, Kergoat M, Mechawar N, Gilbert A, Bocti C, Breitner JC, Calon F, Chertkow H, Doyon J, Fuhrer R, et al. P4-091: CIMA-Q: QUEBEC's CONSORTIUM TO IDENTIFY PRODROMAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P817-P818. DOI: 10.1016/J.Jalz.2014.05.1606  0.357
2014 Cheewakriengkrai L, Mohades S, Shin M, Mathotaarachchi SS, Wang S, Benedet AL, Beaudry T, Fonov VS, Leuzy A, Manitsirikul S, Schilling LP, Rosa-Neto P, Gauthier S. Correlations Between Various Moca Cognitive Domain Assessments And Regional Brain Fdg-Pet Hypometabolism Alzheimers & Dementia. 10: 834. DOI: 10.1016/J.Jalz.2014.05.153  0.364
2014 Wang S, Carbonell F, Beaudry T, Mathotaarachchi SS, Leuzy A, Mohades S, Zimmer ER, Fonov V, Bellec P, Gauthier S, Rosa-Neto P. Glucose Metabolism Impact On Functional Connectivity In Alzheimer'S Disease Alzheimers & Dementia. 10: 80. DOI: 10.1016/J.Jalz.2014.05.146  0.329
2014 Mathotaarachchi SS, Mohades S, Zimmer ER, Carbonell F, Beaudry T, Parent M, Benedet AL, Wang S, Shin M, Fonov VS, Cheewakriengkrai L, Leuzy A, Schilling LP, Manitsirikul S, Eskildsen S, ... ... Gauthier S, et al. Regional Association Maps Describe Dynamic Architecture Of Amyloidosis And Hypometabolism In Alzheimer'S Disease Alzheimers & Dementia. 10: 108. DOI: 10.1016/J.Jalz.2014.05.1276  0.308
2014 Parent M, Zimmer ER, Shin M, Kang MS, Carmo SD, Aliaga A, Reininger C, Soucy J, Gauthier S, Cuello AC, Rosa-Neto P. Longitudinal Follow-Up Of Amyloidosis And Glucose Hypometabolism In A Transgenic Rat Model Of Alzheimer'S Disease Alzheimers & Dementia. 10: 413. DOI: 10.1016/J.Jalz.2014.05.052  0.341
2014 Zimmer ER, Parent M, Carbonnell F, Leuzy A, Shin M, Kang MS, Aliaga A, Wang S, Mathotaarachchi SS, Schirrmacher ES, Soucy J, Gauthier S, Cuello C, Rosa-Neto P. Early Remodeling Of Brain Metabolic Architecture In A Transgenic Rat Model Of Alzheimer'S Disease Alzheimers & Dementia. 10: 24. DOI: 10.1016/J.Jalz.2014.05.043  0.344
2013 Masellis M, Sherborn K, Neto P, Sadovnick DA, Hsiung GY, Black SE, Prasad S, Williams M, Gauthier S. Early-onset dementias: diagnostic and etiological considerations. Alzheimer's Research & Therapy. 5: S7. PMID 24565469 DOI: 10.1186/Alzrt197  0.357
2013 Patterson C, Gauthier S. Diagnosis and treatment of dementia: the fourth canadian consensus conference. Alzheimer's Research & Therapy. 5: S1. PMID 24565164 DOI: 10.1186/Alzrt196  0.324
2013 Gauthier S, Rosa-Neto P. Dementia: Disclosure of results to participants in dementia research. Nature Reviews. Neurology. 9: 608-9. PMID 24145370 DOI: 10.1038/Nrneurol.2013.213  0.368
2013 Rowley J, Fonov V, Wu O, Eskildsen SF, Schoemaker D, Wu L, Mohades S, Shin M, Sziklas V, Cheewakriengkrai L, Shmuel A, Dagher A, Gauthier S, Rosa-Neto P. White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease. Plos One. 8: e74776. PMID 24086371 DOI: 10.1371/Journal.Pone.0074776  0.717
2013 Palmour N, Vanderbyl BL, Zimmerman E, Gauthier S, Racine E. Alzheimer's disease dietary supplements in websites. Hec Forum : An Interdisciplinary Journal On Hospitals' Ethical and Legal Issues. 25: 361-82. PMID 23765585 DOI: 10.1007/S10730-013-9217-1  0.355
2013 Rive B, Gauthier S, Costello S, Marre C, François C. Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease. Cns Drugs. 27: 573-82. PMID 23765561 DOI: 10.1007/S40263-013-0074-X  0.379
2013 Gauthier S, Robillard A, Cohen S, Black S, Sampalis J, Colizza D, de Takacsy F, Schecter R. Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study. Current Medical Research and Opinion. 29: 989-1000. PMID 23647369 DOI: 10.1185/03007995.2013.802230  0.41
2013 Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues. Progress in Neurobiology. 110: 102-13. PMID 23578568 DOI: 10.1016/J.Pneurobio.2013.01.003  0.379
2013 Herrmann N, Gauthier S, Boneva N, Lemming OM. A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease. International Psychogeriatrics / Ipa. 25: 919-27. PMID 23472619 DOI: 10.1017/S1041610213000239  0.364
2013 Arrighi HM, Gélinas I, McLaughlin TP, Buchanan J, Gauthier S. Longitudinal changes in functional disability in Alzheimer's disease patients. International Psychogeriatrics / Ipa. 25: 929-37. PMID 23406898 DOI: 10.1017/S1041610212002360  0.437
2013 Cheewakriengkrai L, Gauthier S. A 10-year perspective on donepezil. Expert Opinion On Pharmacotherapy. 14: 331-8. PMID 23316713 DOI: 10.1517/14656566.2013.760543  0.382
2013 Dubois B, Gauthier S, Cummings J. The utility of the new research diagnostic criteria for Alzheimer's disease. International Psychogeriatrics / Ipa. 25: 175-7. PMID 23148941 DOI: 10.1017/S1041610212002098  0.419
2013 Gauthier S, Molinuevo JL. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 326-31. PMID 23110864 DOI: 10.1016/J.Jalz.2011.11.005  0.397
2013 Clément F, Gauthier S, Belleville S. Executive functions in mild cognitive impairment: emergence and breakdown of neural plasticity. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 1268-79. PMID 22841389 DOI: 10.1016/J.Cortex.2012.06.004  0.338
2013 Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study. International Journal of Geriatric Psychiatry. 28: 164-72. PMID 22492589 DOI: 10.1002/Gps.3805  0.442
2013 Leuzy A, Rowley J, Rosa-Neto P, Gauthier S. In vivo characterization of metabotropic glutamate receptor type five vulnerability in behavioral variant FTD and Alzheimer's disease: An [11C]ABP688 PET/ VBM /DBM study Alzheimers & Dementia. 9: 846. DOI: 10.1016/J.Jalz.2013.08.012  0.409
2013 Shin M, Parent M, Wang S, Fonov V, Allard S, Carmo SD, Gauthier S, Cuello C, Rosa-Neto P. Assessment of hippocampal volumetry in a transgenic Alzheimer's disease rat Alzheimers & Dementia. 9: 248. DOI: 10.1016/J.Jalz.2013.05.488  0.375
2013 Gauthier S, Jia J, Belleville S, Doudet D, Hsiung G, Labbe A, Li D, Qin W, Rosa-Neto P, Sadovnick D, Soucy J, Wu L. P1-149: Canada-China Cohort Study of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P204-P204. DOI: 10.1016/J.Jalz.2013.05.371  0.365
2013 Parent M, Wang S, Mohades S, Beaudry T, Rowley J, Cheewakriengkrai L, Shin M, Leuzy A, Gauthier S, Rosa-Neto P. Posterior cingulate network adaptation in Alzheimer's disease Alzheimers & Dementia. 9: 75. DOI: 10.1016/J.Jalz.2013.05.122  0.35
2013 Zimmer E, Rowley J, Parent M, Leuzy A, Cheewakriengkrai L, Shin M, Wang S, Dauar M, Mohades S, Schirrmacher ES, Soucy J, Kostikov A, Guiot M, Gauthier S, Rosa-Neto P. [18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue Alzheimers & Dementia. 9: 584. DOI: 10.1016/J.Jalz.2013.05.1161  0.326
2013 Mohades S, Dubois J, Parent M, Cheewakriengkrai L, Rowley J, Shin M, Beaudry T, Eskildsen S, Leuzy A, Dauar MT, Fonov V, Gauthier S, Rosa-Neto P. IC-P-115: Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 9: P70-P70. DOI: 10.1016/J.Jalz.2013.05.112  0.419
2013 Parent M, Shin M, Carmo SD, Aliaga A, Gauthier S, Cuello C, Rosa-Neto P. Resting-state connectivity impairment in a rat model of Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.042  0.371
2013 Dauar M, Rowley J, Mohades S, Shin M, Leuzy A, Wu L, Cheewakriengkrai L, Eskildsen S, Fonov V, Gauthier S, Rosa-Neto P. Association between memory and amyloid deposition–synaptic dysfunction in people with EMCI, LMCI and Alzheimer’s disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.030  0.34
2013 Dauar M, Rowley J, Mohades S, Shin M, Leuzy A, Wu L, Cheewakriengkrai L, Eskildsen S, Fonov V, Gauthier S, Rosa-Neto P. Association between memory and amyloid deposition and synaptic dysfunction in EMCI, LMCI and Alzheimer’s disease patients Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.069  0.32
2012 Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Canadian Geriatrics Journal : Cgj. 15: 120-6. PMID 23259025 DOI: 10.5770/Cgj.15.49  0.313
2012 Gauthier S, Wu L, Rosa-Neto P, Jia J. Prevention strategies for Alzheimer's disease. Translational Neurodegeneration. 1: 13. PMID 23210473 DOI: 10.1186/2047-9158-1-13  0.417
2012 Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. Plos One. 7: e47905. PMID 23112868 DOI: 10.1371/Journal.Pone.0047905  0.358
2012 Lee WJ, Tsai CF, Gauthier S, Wang SJ, Fuh JL. The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia. International Psychogeriatrics / Ipa. 24: 1980-7. PMID 22835209 DOI: 10.1017/S1041610212001317  0.348
2012 Liu J, Wang LN, Tan JP, Ji P, Gauthier S, Zhang YL, Ma TX, Liu SN. Burden, anxiety and depression in caregivers of veterans with dementia in Beijing. Archives of Gerontology and Geriatrics. 55: 560-3. PMID 22749403 DOI: 10.1016/J.Archger.2012.05.014  0.319
2012 Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S. Early-onset familial Alzheimer's disease (EOFAD). The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 436-45. PMID 22728850 DOI: 10.1017/S0317167100013949  0.377
2012 Leuzy A, Gauthier S. Ethical issues in Alzheimer's disease: an overview. Expert Review of Neurotherapeutics. 12: 557-67. PMID 22550984 DOI: 10.1586/Ern.12.38  0.417
2012 Gauthier S. Pharmacotherapy of mild cognitive impairment. Dialogues in Clinical Neuroscience. 6: 391-5. PMID 22034396  0.302
2012 Ihl R, Ferris S, Robert P, Winblad B, Gauthier S, Tennigkeit F. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 15-21. PMID 21384431 DOI: 10.1002/Gps.2679  0.355
2012 Gauthier S. 28 The challenge of treating prodromal Alzheimer's disease patients Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.046  0.395
2012 Gauthier S, Rosa-Neto P. 27 EOFAD: Opportunities for proof-of-concept studies to modify disease progresssion Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.045  0.305
2012 Mohades S, Rowley J, Leuzy A, Wu L, Dauar MT, Fonov V, Shin M, Zaccaria C, Gauthier S, Rosa-Neto P. Association of brain amyloidosis and metabolism with the Trail Making Test in MCI and Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.111  0.372
2012 Belleville S, Lepage E, Kergoat M, Gauthier S. Measuring multiple cognitive domains optimizes prediction of future decline in persons with mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2158  0.31
2012 Gauthier S, Black S, Cohen S, Allain R, Hubert M, Schecter R, Tackacsy Fd, Rehel B. Eighteen-month follow-up data from the Canadian EMBRACE registry with the rivastigmine patch in patients with Alzheimer's disease Alzheimers & Dementia. 8: 600. DOI: 10.1016/J.Jalz.2012.05.2087  0.372
2012 Leuzy A, Rowley J, Mohades S, Dauar M, Wu L, Gauthier S, Rosa-Neto P. Confrontation naming deficits are associated with amyloidosis in early MCI and with synaptic dysfunction in late MCI and Alzheimer's disease: An [18F]AV45/[18F]FDG-PET study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1380  0.329
2012 Dauar M, Rowley J, Wu L, Shin M, Mohades S, Fonov V, Leuzy A, Gauthier S, Rosa-Neto P. Association between brain amyloidosis, synaptic dysfunction and cognitive performance measured with ADAS-cog and MMSE scores in early MCI, late MCI and Alzheimer's disease Alzheimers & Dementia. 8: 524. DOI: 10.1016/J.Jalz.2012.05.116  0.418
2012 Rowley J, Wu L, Mohades S, Dauar M, Leuzy A, Shin M, Zaccaria C, Fonov V, Gauthier S, Rosa-Neto P. Brain amyloid deposition and metabolism in early and late mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.038  0.345
2012 Gauthier S. Pharmacological treatment of Alzheimer's disease Alzheimers & Dementia. 8: 2. DOI: 10.1016/J.Jalz.2012.05.007  0.391
2011 Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, Duong A, Suhy J, Oh J, Lau WC, Sampalis J. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study). Archives of Medical Science : Ams. 7: 102-11. PMID 22291741 DOI: 10.5114/Aoms.2011.20612  0.42
2011 Wu L, Rosa-Neto P, Gauthier S. Use of biomarkers in clinical trials of Alzheimer disease: from concept to application. Molecular Diagnosis & Therapy. 15: 313-25. PMID 22188635 DOI: 10.1007/Bf03256467  0.395
2011 Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 579-92. PMID 22055975 DOI: 10.1016/J.Jalz.2011.02.009  0.307
2011 Gauthier S. Treatment of Alzheimer disease: the past, the present, and the future. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 56: 577-8. PMID 22014689 DOI: 10.1177/070674371105601001  0.452
2011 Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, et al. Prevention trials in Alzheimer's disease: an EU-US task force report. Progress in Neurobiology. 95: 594-600. PMID 21925234 DOI: 10.1016/J.Pneurobio.2011.08.014  0.403
2011 Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S. The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia. 49: 3027-35. PMID 21763333 DOI: 10.1016/J.Neuropsychologia.2011.07.001  0.321
2011 Gauthier S, Patterson C, Gordon M, Soucy JP, Schubert F, Leuzy A. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 330-2. PMID 21575874 DOI: 10.1016/J.Jalz.2011.03.006  0.358
2011 Belleville S, Clément F, Mellah S, Gilbert B, Fontaine F, Gauthier S. Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. Brain : a Journal of Neurology. 134: 1623-34. PMID 21427462 DOI: 10.1093/Brain/Awr037  0.347
2011 Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 377: 1019-31. PMID 21371747 DOI: 10.1016/S0140-6736(10)61349-9  0.315
2011 Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. International Journal of Geriatric Psychiatry. 26: 150-7. PMID 20597141 DOI: 10.1002/Gps.2507  0.397
2011 Tillement P, Hauw J, Dubois B, Racine É, Gzil F, Duckaerts C, Amouyel P, Quirion R, Krantic S, Papadopoulos V, Belleville S, Gauthier S, Michel J, Bergman H, Poncet M. Maladie d’Alzheimer : progrès scientifiques récents et perspectives médicales Bulletin De L Academie Nationale De Medecine. 195: 1743-1747. DOI: 10.1016/S0001-4079(19)31973-9  0.378
2011 Rosa-Neto P, Gauthier S, Soucy J, Rowley J, Mohades S, Schoemaker D, Minuzzi L. PET and tissue autoradiography evidence of decline of metabotropic glutamate receptor type 5 (mGluR5) in the prefrontal cortex of Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.278  0.671
2011 Schoemaker D, Soder R, Sziklas V, Rowley J, Carbonell F, Mohades S, Shmuel A, Gauthier S, Dagher A, Rosa-Neto P. IC-P-173: Hippocampal resting-state connectivity lateralize memory function in aMCI brain networks Alzheimer's & Dementia. 7: S78-S79. DOI: 10.1016/J.Jalz.2011.05.187  0.661
2011 Schoemaker D, Rowley J, Soder R, Carbonell F, Mohades S, Sziklas V, Fonov V, Dagher A, Shmuel A, Evans A, Gauthier S, Rosa-Neto P. aMCI delay recall performance is associated with white and grey matter abnormalities in the left hippocampal formation: A DTI and cortical thickness study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.186  0.739
2011 Rowley J, Schoemaker D, Mohades S, Fonov V, Wu O, Dagher A, Shmuel A, Gauthier S, Rosa-Neto P. Declines in entorhinal cortex structural connectivity in amnestic mild cognitive impairment Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.134  0.69
2010 Winblad B, Gauthier S, Aström D, Stender K. Memantine benefits functional abilities in moderate to severe Alzheimer's disease. The Journal of Nutrition, Health & Aging. 14: 770-4. PMID 21085908 DOI: 10.1007/s12603-010-0122-x  0.318
2010 Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R. Predicting cognitive decline in Alzheimer's disease: an integrated analysis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 431-9. PMID 21044773 DOI: 10.1016/J.Jalz.2010.04.003  0.442
2010 Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. Neurology. 9: 1118-27. PMID 20934914 DOI: 10.1016/S1474-4422(10)70223-4  0.431
2010 Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT. The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease. Current Medical Research and Opinion. 26: 2441-7. PMID 20828359 DOI: 10.1185/03007995.2010.513849  0.352
2010 Massoud F, Gauthier S. Update on the pharmacological treatment of Alzheimer's disease. Current Neuropharmacology. 8: 69-80. PMID 20808547 DOI: 10.2174/157015910790909520  0.412
2010 Robert P, Ferris S, Gauthier S, Ihl R, Winblad B, Tennigkeit F. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research & Therapy. 2: 24. PMID 20796301 DOI: 10.1186/Alzrt48  0.387
2010 Desmarais JE, Gauthier S. Alzheimer disease: clinical use of cholinergic drugs in Alzheimer disease. Nature Reviews. Neurology. 6: 418-20. PMID 20689561 DOI: 10.1038/Nrneurol.2010.105  0.395
2010 Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J. Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis. Journal of Alzheimer's Disease : Jad. 21: 843-51. PMID 20634594 DOI: 10.3233/Jad-2010-100078  0.381
2010 Gauthier S, Garcia A, Sano M, Robert P, Senanarong V, Woodward M, Brodaty H. Priorities for research consortia on Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 359-62. PMID 20630416 DOI: 10.1016/J.Jalz.2010.05.2017  0.397
2010 Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. International Psychogeriatrics / Ipa. 22: 973-83. PMID 20534179 DOI: 10.1017/S1041610210000888  0.412
2010 Gauthier S, Juby A, Dalziel W, Réhel B, Schecter R. Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE). Current Medical Research and Opinion. 26: 1149-60. PMID 20230208 DOI: 10.1185/03007991003688888  0.337
2010 Gauthier S, Leuzy A. Diagnosis of prodromal Alzheimer's disease: do you really want to know? The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 37: 2. PMID 20169766 DOI: 10.1017/S0317167100009574  0.393
2010 Plosker GL, Gauthier S. Spotlight on cerebrolysin in dementia. Cns Drugs. 24: 263-6. PMID 20155999 DOI: 10.2165/11204820-000000000-00000  0.384
2010 Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C. Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics / Ipa. 22: 346-72. PMID 20096151 DOI: 10.1017/S1041610209991505  0.368
2010 Black SE, Gauthier S, Dalziel W, Keren R, Correia J, Hew H, Binder C. Canadian Alzheimer's disease caregiver survey: baby-boomer caregivers and burden of care. International Journal of Geriatric Psychiatry. 25: 807-13. PMID 20029824 DOI: 10.1002/Gps.2421  0.375
2010 Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, et al. An exploration of cognitive subgroups in Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 16: 233-43. PMID 19958568 DOI: 10.1017/S1355617709991160  0.428
2010 Bélanger S, Belleville S, Gauthier S. Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: effect of congruency proportion in a Stroop task. Neuropsychologia. 48: 581-90. PMID 19879885 DOI: 10.1016/J.Neuropsychologia.2009.10.021  0.395
2010 Moorhouse P, Song X, Rockwood K, Black S, Kertesz A, Gauthier S, Feldman H. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study. Journal of the Neurological Sciences. 288: 142-6. PMID 19840883 DOI: 10.1016/J.Jns.2009.09.017  0.404
2010 Aarsland D, Ehrt U, Gauthier S. Rivastigmine for the treatment of Parkinson’s disease dementia Aging Health. 6: 277-284. DOI: 10.2217/Ahe.10.30  0.373
2010 Gauthier S. Cognition initiative to address the need for expanded domains and increased measurement sensitivity at mild levels of impairment Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.530  0.309
2010 Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Holtoff V, Sternberg K, Tennigkeit F. The Relevant Outcome Scale for Alzheimer's Disease (ROSA): A new instrument for daily medical practice Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1165  0.429
2009 Brambati SM, Belleville S, Kergoat MJ, Chayer C, Gauthier S, Joubert S. Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin? Dementia and Geriatric Cognitive Disorders. 28: 541-9. PMID 20016185 DOI: 10.1159/000255240  0.382
2009 Gauthier S, Scheltens P. Can we do better in developing new drugs for Alzheimer's disease? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 489-91. PMID 19896588 DOI: 10.1016/J.Jalz.2009.09.002  0.361
2009 Plosker GL, Gauthier S. Cerebrolysin: a review of its use in dementia. Drugs & Aging. 26: 893-915. PMID 19848437 DOI: 10.2165/11203320-000000000-00000  0.41
2009 Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 28: 244-51. PMID 19786776 DOI: 10.1159/000241877  0.415
2009 Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 375-9. PMID 19751916 DOI: 10.1016/J.Jalz.2009.04.1236  0.342
2009 Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 369-74. PMID 19751915 DOI: 10.1016/J.Jalz.2009.05.604  0.365
2009 Suh GH, Wimo A, Gauthier S, O'Connor D, Ikeda M, Homma A, Dominguez J, Yang BM. International price comparisons of Alzheimer's drugs: a way to close the affordability gap. International Psychogeriatrics / Ipa. 21: 1116-26. PMID 19735595 DOI: 10.1017/S104161020999086X  0.3
2009 Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, Gauthier S, Gómez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, et al. Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 361-6. PMID 19560106 DOI: 10.1016/J.Jalz.2009.05.158  0.329
2009 Gauthier S, Aisen PS, Ferris SH, Saumier D, Duong A, Haine D, Garceau D, Suhy J, Oh J, Lau W, Sampalis J. Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. The Journal of Nutrition, Health & Aging. 13: 550-7. PMID 19536424 DOI: 10.1007/S12603-009-0106-X  0.415
2009 Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews. Neurology. 5: 245-55. PMID 19488082 DOI: 10.1038/Nrneurol.2009.39  0.331
2009 Gauthier S, O'Brien J. Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. International Psychogeriatrics / Ipa. 21: 454-6. PMID 19371449 DOI: 10.1017/S1041610209009041  0.349
2009 Gauthier S, Poirier J. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 147-8. PMID 19328447 DOI: 10.1016/J.Jalz.2009.01.007  0.373
2009 Villeneuve S, Belleville S, Massoud F, Bocti C, Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 27: 375-81. PMID 19321941 DOI: 10.1159/000209965  0.347
2009 Saumier D, Aisen PS, Gauthier S, Vellas B, Ferris SH, Duong A, Suhy J, Oh J, Lau W, Garceau D, Haine D, Sampalis J. Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience. The Journal of Nutrition, Health & Aging. 13: 370-2. PMID 19300884 DOI: 10.1007/S12603-009-0047-4  0.338
2009 Hudon C, Belleville S, Gauthier S. The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease. Brain and Cognition. 70: 171-9. PMID 19250730 DOI: 10.1016/J.Bandc.2009.01.009  0.401
2009 Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, Fillit H, Frisoni GB, Froelich L, Gauthier S, Jones R, Jönsson L, Khachaturian Z, Morris JC, Orgogozo JM, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. Journal of Alzheimer's Disease : Jad. 16: 235-70. PMID 19221415 DOI: 10.3233/Jad-2009-0971  0.359
2009 Robert P, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, Verhey FR, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, ... Gauthier S, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. European Psychiatry : the Journal of the Association of European Psychiatrists. 24: 98-104. PMID 19201579 DOI: 10.1016/J.Eurpsy.2008.09.001  0.369
2009 Gauthier S. Pharmacotherapy of Parkinson disease dementia and Lewy body dementia. Frontiers of Neurology and Neuroscience. 24: 135-9. PMID 19182471 DOI: 10.1159/000197892  0.373
2009 Erkinjuntti T, Gauthier S. The concept of vascular cognitive impairment. Frontiers of Neurology and Neuroscience. 24: 79-85. PMID 19182465 DOI: 10.1159/000197886  0.348
2009 Gauthier S. Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease. Evidence-Based Mental Health. 12: 21. PMID 19176780 DOI: 10.1136/Ebmh.12.1.21  0.423
2009 Villeneuve S, Belleville S, Lacombe J, Labelle M, Enriquez-Rosas A, Gauthier S. Episodic memory deficits in vascular and non vascular mild cognitive impairment Journal of the Neurological Sciences. 283: 291. DOI: 10.1016/J.Jns.2009.02.196  0.351
2009 Minuzzi L, Quirion R, Gauthier S, Rosa-Neto P. IC-P-140: Declines of hippocampal metabotropic glutamate receptor in Alzheimer's disease Alzheimer's & Dementia. 5: P56-P57. DOI: 10.1016/J.Jalz.2009.05.112  0.504
2009 Robert P, Ferris S, Gauthier S, Gatz G, Winblad B, Tennigkeit F. The need for a new practical Alzheimer's disease scale Alzheimers & Dementia. 5: 186. DOI: 10.1016/J.Jalz.2009.04.052  0.359
2008 Herrmann N, Gauthier S. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 179: 1279-87. PMID 19047609 DOI: 10.1503/Cmaj.070804  0.37
2008 Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. Plos One. 3: e3637. PMID 18982063 DOI: 10.1371/Journal.Pone.0003637  0.328
2008 Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, Tolosa E, Dubois B. Diagnosis and management of Parkinson's disease dementia. International Journal of Clinical Practice. 62: 1581-7. PMID 18822028 DOI: 10.1111/J.1742-1241.2008.01869.X  0.397
2008 Gauthier S, Dubois B, Feldman H, Scheltens P. Revised research diagnostic criteria for Alzheimer's disease. The Lancet. Neurology. 7: 668-70. PMID 18635012 DOI: 10.1016/S1474-4422(08)70146-7  0.38
2008 Gauthier S, Poirier J. Current and future management of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S48-50. PMID 18632000 DOI: 10.1016/J.Jalz.2007.11.010  0.393
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/J.Jalz.2008.03.005  0.382
2008 Gauthier S. Symptomatic therapeutic aspects in Alzheimer's disease. Handbook of Clinical Neurology. 89: 269-71. PMID 18631751 DOI: 10.1016/S0072-9752(07)01225-0  0.339
2008 Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort. Dementia and Geriatric Cognitive Disorders. 25: 483-90. PMID 18417973 DOI: 10.1159/000126499  0.435
2008 Hudon C, Belleville S, Gauthier S. The association between depressive and cognitive symptoms in amnestic mild cognitive impairment. International Psychogeriatrics / Ipa. 20: 710-23. PMID 18397547 DOI: 10.1017/S1041610208007114  0.317
2008 Belleville S, Bherer L, Lepage E, Chertkow H, Gauthier S. Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychologia. 46: 2225-33. PMID 18374374 DOI: 10.1016/J.Neuropsychologia.2008.02.012  0.333
2008 Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology. 70: 2024-35. PMID 18322263 DOI: 10.1212/01.Wnl.0000303815.69777.26  0.349
2008 Erkinjuntti T, Gauthier S, Bullock R, Kurz A, Hammond G, Schwalen S, Zhu Y, Brashear R. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6). Journal of Psychopharmacology (Oxford, England). 22: 761-8. PMID 18308781 DOI: 10.1177/0269881107083028  0.435
2008 Clément F, Belleville S, Gauthier S. Cognitive complaint in mild cognitive impairment and Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 14: 222-32. PMID 18282320 DOI: 10.1017/S1355617708080260  0.42
2008 Reisberg B, Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics / Ipa. 20: 1-16. PMID 18072981 DOI: 10.1017/S1041610207006412  0.419
2008 Gauthier S, Loft H, Cummings J. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. International Journal of Geriatric Psychiatry. 23: 537-45. PMID 18058838 DOI: 10.1002/Gps.1949  0.348
2008 Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, ... ... Gauthier S, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology. 65: 45-53. PMID 17998437 DOI: 10.1001/Archneurol.2007.3  0.381
2008 Poirier J, Gauthier S. Pharmacogenomics and the treatment of sporadic Alzheimer's disease: A decade of progress Current Pharmacogenomics and Personalized Medicine. 6: 63-76. DOI: 10.2174/187569208784017494  0.444
2008 Wilkinson D, Gauthier S, Rive B. P.5.a.007 Memantine decreases, and prevents the emergence of, key behavioural symptoms of Alzheimer's disease European Neuropsychopharmacology. 18. DOI: 10.1016/S0924-977X(08)70762-4  0.371
2008 Bocti C, Belleville S, Labelle M, Massoud F, Gauthier S. P1-155: The value of the HIV dementia scale in vascular mild cognitive impairment Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.743  0.323
2008 Gauthier S, Lopez O, Schwam E, Feldman H, Waldemar G, Jones RW, Wilkinson D, Zhang R, Schindler R. P4-367: Impact of donepezil therapy on function in relation to MMSE in patients with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2438  0.373
2008 Gauthier S, Guilhaume-Goulant C, Rive B. P4-317: Memantine decreases and prevents the emergence of key behavioural symptoms of Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2387  0.371
2008 Fokkens J, Ferris S, Robert P, Winblad B, Gauthier S. P3-009: Development of a language assessment tool for patients with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1572  0.416
2007 Herrmann N, Gauthier S, Lysy PG. Clinical practice guidelines for severe Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 385-97. PMID 19595959 DOI: 10.1016/J.Jalz.2007.07.007  0.388
2007 Seow D, Gauthier S. Pharmacotherapy of Alzheimer disease. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 52: 620-9. PMID 18020110 DOI: 10.1177/070674370705201003  0.364
2007 Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Alzhemed: a potential treatment for Alzheimer's disease. Current Alzheimer Research. 4: 473-8. PMID 17908052 DOI: 10.2174/156720507781788882  0.419
2007 Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. The Lancet. Neurology. 6: 734-46. PMID 17616482 DOI: 10.1016/S1474-4422(07)70178-3  0.414
2007 Belleville S, Chertkow H, Gauthier S. Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology. 21: 458-69. PMID 17605579 DOI: 10.1037/0894-4105.21.4.458  0.384
2007 Gauthier S, Juby A, Rehel B, Schecter R. EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease. International Journal of Clinical Practice. 61: 886-95. PMID 17504350 DOI: 10.1111/J.1742-1241.2007.01387.X  0.347
2007 Blair M, Kertesz A, Davis-Faroque N, Hsiung GY, Black SE, Bouchard RW, Gauthier S, Guzman DA, Hogan DB, Rockwood K, Feldman H. Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study. Dementia and Geriatric Cognitive Disorders. 23: 406-15. PMID 17446701 DOI: 10.1159/000101908  0.386
2007 Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry. 22: 806-12. PMID 17199235 DOI: 10.1002/Gps.1746  0.344
2007 Rockwood K, Moorhouse PK, Song X, MacKnight C, Gauthier S, Kertesz A, Montgomery P, Black S, Hogan DB, Guzman A, Bouchard R, Feldman H. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. Journal of the Neurological Sciences. 252: 106-12. PMID 17189642 DOI: 10.1016/J.Jns.2006.10.015  0.443
2006 Gauthier S, Vellas B, Farlow M, Burn D. Aggressive course of disease in dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 210-7. PMID 19595889 DOI: 10.1016/J.Jalz.2006.03.002  0.397
2006 Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson's disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 175: 1545-52. PMID 17146092 DOI: 10.1503/Cmaj.060542  0.359
2006 Gauthier S, Juby A, Morelli L, Rehel B, Schecter R. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study. Current Medical Research and Opinion. 22: 2251-65. PMID 17076986 DOI: 10.1185/030079906X132749  0.372
2006 Belleville S, Gilbert B, Fontaine F, Gagnon L, Ménard E, Gauthier S. Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dementia and Geriatric Cognitive Disorders. 22: 486-99. PMID 17050952 DOI: 10.1159/000096316  0.324
2006 Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauthier SG, Loy-English I, Hogan DB, Kertesz A, Rockwood K, Feldman HH. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dementia and Geriatric Cognitive Disorders. 22: 413-20. PMID 16966831 DOI: 10.1159/000095751  0.345
2006 Gauthier S, Herrmann N, Ferreri F, Agbokou C, Agokou C. Use of memantine to treat Alzheimer's disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 175: 501-2. PMID 16940271 DOI: 10.1503/Cmaj.1060168  0.369
2006 Hudon C, Belleville S, Souchay C, Gély-Nargeot MC, Chertkow H, Gauthier S. Memory for gist and detail information in Alzheimer's disease and mild cognitive impairment. Neuropsychology. 20: 566-77. PMID 16938019 DOI: 10.1037/0894-4105.20.5.566  0.412
2006 Gauthier S. Cholinesterase inhibitors in late-stage Alzheimer's disease. The Lancet. Neurology. 5: 468-9. PMID 16713915 DOI: 10.1016/S1474-4422(06)70454-9  0.367
2006 Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, et al. Mild cognitive impairment. Lancet. 367: 1262-70. PMID 16631882 DOI: 10.1016/S0140-6736(06)68542-5  0.403
2006 Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, Chris M. Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 33: 6-26. PMID 16583717 DOI: 10.1017/S0317167100004649  0.422
2006 Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D, Kertesz A, Loy-English I, Beattie BL, Sadovnick AD, Feldman HH. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology. 66: 523-8. PMID 16505306 DOI: 10.1212/01.Wnl.0000198255.84842.06  0.365
2006 Rockwood K, Black SE, Song X, Hogan DB, Gauthier S, MacKnight C, Vandorpe R, Guzman A, Montgomery P, Kertesz A, Bouchard RW, Feldman H. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. Journal of the Neurological Sciences. 240: 7-14. PMID 16212979 DOI: 10.1016/J.Jns.2005.08.010  0.355
2006 Gauthier S. The future of Alzheimer's disease treatment Aging Health. 2: 35-36. DOI: 10.2217/1745509X.2.1.35  0.365
2006 Gauthier S. Current and future therapies for Alzheimer's disease and related disorders Future Neurology. 1: 741-745. DOI: 10.2217/14796708.1.6.741  0.4
2006 Andrews JS, Ball D, Ye W, Gauthier S, Rentz DM, Stern Y. P1-310: PATTERNS OF CHANGE IN DEPENDENCE LEVELS FOR COMMUNITY-DWELLING ALZHEIMER'S PATIENTS: 36-MONTH RESULTS FROM THE GERAS OBSERVATIONAL STUDY Alzheimer's & Dementia. 14: P409-P410. DOI: 10.1016/J.Jalz.2018.06.317  0.305
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Gauthier S, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.362
2005 Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Archives of Neurology. 62: 1164-6; discussion 1. PMID 16009780 DOI: 10.1001/Archneur.62.7.1164  0.43
2005 Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. International Journal of Geriatric Psychiatry. 20: 559-69. PMID 15920715 DOI: 10.1002/Gps.1325  0.414
2005 Gauthier S, Wirth Y, Möbius HJ. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. International Journal of Geriatric Psychiatry. 20: 459-64. PMID 15852444 DOI: 10.1002/Gps.1341  0.342
2005 Gauthier S. Drugs for Alzheimer's disease and related dementias. Bmj (Clinical Research Ed.). 330: 857-8. PMID 15831849 DOI: 10.1136/Bmj.330.7496.857  0.427
2005 Gauthier S. Pharmacotherapy of amnestic mild cognitive impairment: lessons from the Memory Impairment Study Aging Health. 1: 37-38. DOI: 10.2217/1745509X.1.1.37  0.378
2004 Erkinjuntti T, Román G, Gauthier S. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Journal of the Neurological Sciences. 226: 63-6. PMID 15537522 DOI: 10.1016/J.Jns.2004.09.018  0.451
2004 Feldman H, Gauthier S, Hecker J, Vellas B, Hux M, Xu Y, Schwam EM, Shah S, Mastey V. Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology. 63: 644-50. PMID 15326236 DOI: 10.1212/01.Wnl.0000134663.79663.6E  0.307
2004 Erkinjuntti T, Román G, Gauthier S. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. Neurological Research. 26: 603-5. PMID 15265282 DOI: 10.1179/01610425017631  0.45
2004 Gauthier S. [Treatment of Alzheimer's disease: general methodological aspects]. Revue Neurologique. 160: 261-4. PMID 15034487 DOI: 10.1016/S0035-3787(04)70901-7  0.39
2004 Erkinjuntti T, Román G, Gauthier S, Feldman H, Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke; a Journal of Cerebral Circulation. 35: 1010-7. PMID 15001795 DOI: 10.1161/01.Str.0000120731.88236.33  0.431
2004 Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology. 61: 59-66. PMID 14732621 DOI: 10.1001/Archneur.61.1.59  0.435
2004 Fornazzari L, Nadkarni S, Surh L, Newton R, Salvarrey A, Apanasiewicz N, Miranda D, George-Hyslop PS, Borrie M, Feldman H, Gauthier S, Gibson R, Guzman A, Keren R, Kertesz A, et al. P2-318 Inter-rater reliability of neuropsychological assessments used in the Canadian study on genetics of Alzheimer's disease associations (GenADA) Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81062-5  0.371
2004 Shah SN, Feldman H, Gauthier S, Hecker J, Vellas B, Hux M, Xu Y, Schwam E, Leaderer M. P1-386 Pharmacoeconomic benefits of donepezil treatment in severe Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80698-5  0.392
2004 Gauthier S, Surh L, Gibson R, Borrie M, Delisle R, Feldman H, Fornazzari L, Guzman D, Khatchaturian Z, Keren R, Kertesz A, Loy-English I, St George-Hyslop P, Pryse-Phillips W, Wherrett J. P1-149 A Canadian study on the genetics of late-onset Alzheimer's disease associations: ‘Genada’ Neurobiology of Aging. 25: S138. DOI: 10.1016/S0197-4580(04)80462-7  0.372
2004 Möbius HJ, Stöffler A, Wirth Y, Gauthier S. O1-05-02 Memantine positively influence behaviour in moderate to severe Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80061-7  0.348
2003 Gauthier S, Rockwood K. Does vascular MCI progress at a different rate than does amnestic MCI? International Psychogeriatrics / Ipa. 15: 257-9. PMID 16191250 DOI: 10.1017/S1041610203009293  0.338
2003 Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Current Medical Research and Opinion. 19: 707-14. PMID 14687441 DOI: 10.1185/030079903125002450  0.34
2003 Marcusson J, Bullock R, Gauthier S, Kurz A, Schwalen S. Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease. Alzheimer Disease & Associated Disorders. 17. PMID 14512822 DOI: 10.1097/00002093-200307003-00005  0.376
2003 Rockwood K, Davis H, MacKnight C, Vandorpe R, Gauthier S, Guzman A, Montgomery P, Black S, Hogan DB, Kertesz A, Bouchard R, Feldman H. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: 237-43. PMID 12945949 DOI: 10.1017/S0317167100002663  0.382
2003 Allain H, Bentué-Ferrer D, Tribut O, Gauthier S, Michel B, Rochelle CD. Alzheimer's disease: the pharmacological pathway Fundamental & Clinical Pharmacology. 17: 419-428. PMID 12914543 DOI: 10.1046/J.1472-8206.2003.00153.X  0.38
2003 Desrosiers RR, Bertrand Y, Nguyen QT, Demeule M, Gabathuler R, Kennard ML, Gauthier S, Béliveau R. Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease. The Biochemical Journal. 374: 463-71. PMID 12809550 DOI: 10.1042/Bj20030240  0.36
2003 Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Journal of the American Geriatrics Society. 51: 737-44. PMID 12757558 DOI: 10.1046/J.1365-2389.2003.51260.X  0.336
2003 Law A, Gauthier S, Quirion R. Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice. Neurobiology of Aging. 24: 187-90. PMID 12493565 DOI: 10.1016/S0197-4580(02)00068-4  0.507
2003 Emre M, Farlow M, Bullock R, Gauthier S, Grossberg G, Potkin SG. Cholinesterase inhibitors in Alzheimer's disease: A consensus view on managing treatment failure Primary Care Psychiatry. 9: 29-30. DOI: 10.1185/135525703125002739  0.335
2003 Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni J, Schwam E. P.4.040 Donepezil has significant functional and behavioral benefits in patients with severe Alzheimer's disease European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)92234-6  0.378
2002 Gauthier S. Current and future therapeutic strategies for Alzheimer's disease and related dementias. Expert Review of Neurotherapeutics. 2: 277-278. PMID 19810857 DOI: 10.1586/14737175.2.3.277  0.416
2002 Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. International Psychogeriatrics / Ipa. 14: 389-404. PMID 12670060 DOI: 10.1017/S104161020200858X  0.335
2002 Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease. Current Medical Research and Opinion. 18: 347-54. PMID 12442882 DOI: 10.1185/030079902125001029  0.441
2002 Panisset M, Gauthier S, Moessler H, Windisch M. Cerebrolysin in Alzheimer's disease: A randomized, double-blind, placebo-controlled trial with a neurotrophic agent Journal of Neural Transmission. 109: 1089-1104. PMID 12111446 DOI: 10.1007/S007020200092  0.386
2002 Law A, O'Donnell J, Gauthier S, Quirion R. Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats. Neuroscience. 112: 267-75. PMID 12044445 DOI: 10.1016/S0306-4522(02)00082-9  0.475
2002 Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial The Lancet. 359: 1283-1290. PMID 11965273 DOI: 10.1016/S0140-6736(02)08267-3  0.443
2002 Gauthier S. Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management. Drugs & Aging. 18: 853-62. PMID 11772125 DOI: 10.2165/00002512-200118110-00006  0.375
2002 Sibley A, MacKnight C, Rockwood K, Fisk J, Gauthier S, Guzman DA, Hogan DB. The effect of the living situation on the severity of dementia at diagnosis. Dementia and Geriatric Cognitive Disorders. 13: 40-5. PMID 11731714 DOI: 10.1159/000048632  0.346
2001 Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Østbye T, Wolfson C, Gauthier S, Verreault R, McDowell I. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 57: 714-6. PMID 11524488 DOI: 10.1212/Wnl.57.4.714  0.37
2001 Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 57: 613-20. PMID 11524468 DOI: 10.1212/Wnl.57.4.613  0.321
2001 Law A, Gauthier S, Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. British Journal of Pharmacology. 133: 1114-24. PMID 11487523 DOI: 10.1038/Sj.Bjp.0704179  0.456
2001 Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, Schneider L, Takeda M, Tariot P, Wilkinson D. Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? International Journal of Geriatric Psychiatry. 16: 653-66. PMID 11466744 DOI: 10.1002/Gps.496  0.412
2001 Gauthier S. Alzheimer's disease: current and future therapeutic perspectives. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 73-89. PMID 11263760 DOI: 10.1016/S0278-5846(00)00149-4  0.419
2001 Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Research. Brain Research Reviews. 35: 73-96. PMID 11245887 DOI: 10.1016/S0165-0173(00)00051-5  0.559
2001 Patterson C, Gauthier S, Bergman H, Cohen C, Feightner JW, Feldman H, Grek A, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 28: S3-16. PMID 11237309 DOI: 10.1017/S0317167100001165  0.311
2001 Gauthier S. Acetylcholinesterase inhibitors in severe dementia European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80095-X  0.331
2001 Law A, Doré S, Blackshaw S, Gauthier S, Quirion R. Corrigendum to “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats” Neuroscience. 104: 281. DOI: 10.1016/S0306-4522(01)00126-9  0.452
2000 Baladi JF, Bailey PA, Black S, Bouchard RW, Farcnik KD, Gauthier S, Kertesz A, Mohr E, Robillard A. Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications. Clinical Therapeutics. 22: 1549-61. PMID 11192146 DOI: 10.1016/S0149-2918(00)83053-2  0.388
2000 Law A, Doré S, Blackshaw S, Gauthier S, Quirion R. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience. 100: 769-75. PMID 11036210 DOI: 10.1016/S0306-4522(00)00316-X  0.467
2000 Gélinas I, Gauthier S, Cyrus P. Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living. Journal of Geriatric Psychiatry and Neurology. 13: 9-16. PMID 10753002 DOI: 10.1177/089198870001300102  0.397
2000 Gauthier S, Feldman H, Hecker J, Vellas B, Subbiah P, Whalen E. Effects of donepezil on behaviour and other domains in moderate to severe Alzheimer's disease European Neuropsychopharmacology. 10: 359-360. DOI: 10.1016/S0924-977X(00)80473-3  0.368
2000 Panisset M, Gauthier S, Moessler H, Windisch M. A randomized, double-blind, placebo-controlled trial with cerebrolysin in Alzheimer's disease European Neuropsychopharmacology. 10: 355. DOI: 10.1016/S0924-977X(00)80462-9  0.338
2000 Panisset M, Gauthier S, Moessler H, Windisch M. Treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial with a neurotrophic agent Neurobiology of Aging. 21: 28. DOI: 10.1016/S0197-4580(00)82803-1  0.33
2000 Pratt RD, Gauthier S, Burns A, Perdomo CA. Donepezil provides long-term clinical benefits for patients with Alzheimer's disease Neurobiology of Aging. 21: 95. DOI: 10.1016/S0197-4580(00)82652-4  0.359
2000 Panisset M, Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E. Use of the severe impairment battery in a clinical trial of donepezil in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 94. DOI: 10.1016/S0197-4580(00)82648-2  0.391
2000 Vellas B, Feldman H, Gauthier S, Hecker J, Subbiah P, Whalen E. Donepezil treatment in patients with moderate to severe Alzheimer's disease reduces caregiver stress Neurobiology of Aging. 21: 94. DOI: 10.1016/S0197-4580(00)82647-0  0.362
2000 Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E. Donepezil provides benefits in global function in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 93. DOI: 10.1016/S0197-4580(00)82641-X  0.404
2000 Gauthier S. Functional assessment tools and their use in long term management of Alzheimer's disease Neurobiology of Aging. 21: 75. DOI: 10.1016/S0197-4580(00)82561-0  0.328
2000 Hecker J, Gauthier S, Vellas B, Subbiah P, Whalen E. Benefits of donepezil in the treatment of behavioral problems in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 162. DOI: 10.1016/S0197-4580(00)82066-7  0.352
2000 Gauthier S, Feldman H, Hecker J, Vellas B, Subbiah P, Whalen E. Benefits of donepezil on performance of basic and instrumental activities of daily living in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 161. DOI: 10.1016/S0197-4580(00)82065-5  0.397
1999 Gauthier S. Acetylcholinesterase inhibitors in the treatment of Alzheimer's disease. Expert Opinion On Investigational Drugs. 8: 1511-1520. PMID 11139807 DOI: 10.1517/13543784.8.10.1511  0.326
1999 Gélinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. American Journal of Occupational Therapy. 53: 471-481. PMID 10500855 DOI: 10.5014/Ajot.53.5.471  0.375
1999 Brodaty H, Dresser R, Eisner M, Erkunjuntti T, Gauthier S, Graham N, Jonker C, Sachs G, Whitehouse PJ. Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia Alzheimer Disease and Associated Disorders. 13: 71-79. PMID 10372949 DOI: 10.1097/00002093-199904000-00003  0.385
1999 Cohen CA, Whitehouse PJ, Post SG, Gauthier S, Eberhart A, LeDuc L. Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force. Alzheimer Disease and Associated Disorders. 13: 66-70. PMID 10372948 DOI: 10.1097/00002093-199904000-00002  0.377
1999 Gauthier S. Do we have a treatment for Alzheimer disease? Yes. Archives of Neurology. 56: 738-9. PMID 10369316 DOI: 10.1001/Archneur.56.6.738  0.379
1999 Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT. The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dementia and Geriatric Cognitive Disorders. 10: 237-44. PMID 10325453 DOI: 10.1159/000017126  0.402
1999 O'Brien BJ, Goeree R, Hux M, Iskedjian M, Blackhouse G, Gagnon M, Gauthier S. Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. Journal of the American Geriatrics Society. 47: 570-8. PMID 10323651 DOI: 10.1111/J.1532-5415.1999.Tb02572.X  0.388
1999 Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Bmj (Clinical Research Ed.). 318: 633-8. PMID 10066203 DOI: 10.1136/Bmj.318.7184.633  0.326
1999 Gauthier S. Managing expectations in the long-term treatment of Alzheimer's disease. Gerontology. 33-8. PMID 9876216 DOI: 10.1159/000052762  0.304
1999 Gauthier S. Update on diagnostic methods, natural history and outcome variables in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2-7. PMID 9853196 DOI: 10.1159/000051197  0.429
1999 Gauthier S. Clinical trials and therapy. Current Opinion in Neurology. 11: 435-8. PMID 9847991 DOI: 10.1097/00019052-199810000-00004  0.35
1999 Gauthier S, Rockwood K, Gélinas I, Sykes L, Teunisse S, Orgogozo JM, Erzigkeit H, Gleeson M, Kittner B, Pontecorvo M, Feldman H. Outcome Measures for the Study of Activities of Daily Living in Vascular Dementia Alzheimer Disease & Associated Disorders. 13: S143-147. DOI: 10.1097/00002093-199912001-00020  0.404
1998 Fisk JD, Sadovnick AD, Cohen CA, Gauthier S, Dossetor J, Eberhart A, LeDuc L. Ethical guidelines of the Alzheimer Society of Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 25: 242-8. PMID 9706727 DOI: 10.1017/S0317167100034089  0.328
1998 Lakmache Y, Lassonde M, Gauthier S, Frigon JY, Lepore F. Interhemispheric disconnection syndrome in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 95: 9042-6. PMID 9671801 DOI: 10.1073/Pnas.95.15.9042  0.417
1998 Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J. HSV-1 in brain and risk of Alzheimer's disease. Lancet. 351: 1330-1. PMID 9643802 DOI: 10.1016/S0140-6736(05)79057-7  0.36
1998 Gauthier S, Gélinas I, Gauthier L. Functional disability in Alzheimer's disease. International Psychogeriatrics. 163-5. PMID 9447439 DOI: 10.1017/S1041610297004857  0.443
1997 Baumgarten M, Battista RN, Infante-Rivard C, Hanley JA, Becker R, Bilker WB, Gauthier S. Use of physician services among family caregivers of elderly persons with dementia Journal of Clinical Epidemiology. 50: 1265-1272. PMID 9393382 DOI: 10.1016/S0895-4356(97)00168-6  0.32
1997 Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I. Prevalence and severity of cognitive impairment with and without dementia in an elderly population Lancet. 349: 1793-1796. PMID 9269213 DOI: 10.1016/S0140-6736(97)01007-6  0.367
1997 Hassainia F, Petit D, Nielsen T, Gauthier S, Montplaisir J. Quantitative EEG and statistical mapping of wakefulness and REM sleep in the evaluation of mild to moderate Alzheimer's disease. European Neurology. 37: 219-24. PMID 9208261 DOI: 10.1159/000117446  0.308
1997 Gauthier S, Baumgarten M, Becker R. Dementia Behavior Disturbance Scale. International Psychogeriatrics. 325-7. PMID 9154583 DOI: 10.1017/S1041610297003566  0.396
1997 Pallister C, Jung SS, Shaw I, Nalbantoglu J, Gauthier S, Cashman NR. Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging. Neurobiology of Aging. 18: 97-103. PMID 8983037 DOI: 10.1016/S0197-4580(96)00207-2  0.356
1997 Gauthier S, Panisset M, Poirier J. Advances in the diagnosis of Alzheimer's disease Biological Psychiatry. 42: 1-6. DOI: 10.1016/S0006-3223(97)87493-8  0.393
1996 Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging Neuroepidemiology. 15: 246-256. PMID 8878077 DOI: 10.1159/000109914  0.328
1996 Gauthier S, Montplaisir J, Petit D, Joanette Y, Feldman H, Mohr E, Nair NP, Poirier J. Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease. Alzheimer Disease and Associated Disorders. 10: 19-21. PMID 8876784 DOI: 10.1097/00002093-199601031-00006  0.372
1996 Montplaisir J, Petit D, McNamara D, Gauthier S. Comparisons between SPECT and quantitative EEG measures of cortical impairment in mild to moderate Alzheimer's disease. European Neurology. 36: 197-200. PMID 8814420 DOI: 10.1159/000117247  0.319
1996 Aubert I, Cécyre D, Gauthier S, Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. The Journal of Comparative Neurology. 369: 31-55. PMID 8723701 DOI: 10.1002/(Sici)1096-9861(19960520)369:1<31::Aid-Cne3>3.0.Co;2-L  0.606
1996 Liu L, Gauthier L, Gauthier S. The Functional Spatial Abilities Questionnaire for Use with Persons Who are in the Early Stages of Alzheimer Disease: Preliminary Data on Reliability and Validity Canadian Journal of Occupational Therapy. 63: 224-233. DOI: 10.1177/000841749606300403  0.358
1995 Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 12260-4. PMID 8618881 DOI: 10.1073/Pnas.92.26.12260  0.694
1995 Mohr E, Feldman H, Gauthier S. Canadian guidelines for the development of antidementia therapies: a conceptual summary. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 22: 62-71. PMID 7750079 DOI: 10.1017/S0317167100040543  0.339
1995 Aubert I, Rowe W, Meaney MJ, Gauthier S, Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67: 277-92. PMID 7675169 DOI: 10.1016/0306-4522(95)00056-O  0.651
1995 Ledoux S, Bergeron C, Nalbantoglu J, Gauthier S, Cashman NR. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome Neuroscience Letters. 193: 137-139. PMID 7478160 DOI: 10.1016/0304-3940(95)11681-L  0.368
1994 Baldereschi M, Amato MP, Nencini P, Pracucci G, Lippi A, Amaducci L, Gauthier S, Beatty L, Quiroga P, Klassen G, Galea A, Muscat P, Osuntokun B, Ogunniyi A, Portera-Sanchez A, et al. Cross–national interrater agreement on the clinical diagnostic criteria for dementia Neurology. 44: 239-242. PMID 8309565 DOI: 10.1212/Wnl.44.2.239  0.415
1994 Aubert I, Poirier J, Gauthier S, Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2476-84. PMID 8182423 DOI: 10.1523/Jneurosci.14-05-02476.1994  0.622
1994 Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Annals of Neurology. 36: 889-95. PMID 7998776 DOI: 10.1002/Ana.410360614  0.391
1993 Poirier J, Bertrand P, Kogan S, Gauthier S, Davignon J, Bouthillier D. Apolipoprotein E polymorphism and Alzheimer's disease The Lancet. 342: 697-699. PMID 8103819 DOI: 10.1016/0140-6736(93)91705-Q  0.403
1993 Gauthier S. Book Review Alzheimer's Disease: New Treatment Strategies Edited by Zaven S. Khachaturian and John P. Blass. 235 pp., illustrated. New York, Marcel Dekker, 1992. $99.75. 0-8247-8620-3 New England Journal of Medicine. 329: 67-68. DOI: 10.1056/Nejm199307013290125  0.339
1992 Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Journal of Neurochemistry. 58: 529-41. PMID 1729398 DOI: 10.1111/J.1471-4159.1992.Tb09752.X  0.661
1992 Aubert I, Cécyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. European Journal of Pharmacology. 217: 173-84. PMID 1425938 DOI: 10.1016/0014-2999(92)90843-S  0.6
1991 Liu L, Gauthier L, Gauthier S. Spatial disorientation in persons with early senile dementia of the Alzheimer type. American Journal of Occupational Therapy. 45: 67-74. PMID 2000926 DOI: 10.5014/Ajot.45.1.67  0.323
1991 Gauthier S, Gauthier L, Bouchard R, Quirion R, Sultan S. Treatment of Alzheimer's disease: Hopes and reality Canadian Journal of Neurological Sciences. 18: 439-441. PMID 1933695 DOI: 10.1017/S0317167100032637  0.549
1990 Baumgarten M, Becker R, Gauthier S. Validity and reliability of the dementia behavior disturbance scale. Journal of the American Geriatrics Society. 38: 221-226. PMID 2313003 DOI: 10.1111/J.1532-5415.1990.Tb03495.X  0.357
1990 Gauthier S, Bouchard R, Lamontagne A, Bailey P, Bergman H, Ratner J, Tesfaye Y, Saint-Martin M, Bacher Y, Carrier L. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. The New England Journal of Medicine. 322: 1272-6. PMID 2183056 DOI: 10.1056/Nejm199005033221804  0.306
1990 Issa AM, Rowe W, Gauthier S, Meaney MJ. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3247-54. PMID 2170594 DOI: 10.1523/Jneurosci.10-10-03247.1990  0.307
1990 Quirion R, Aubert I, Robitaille Y, Gauthier S, Araujo DM, Chabot JG. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clinical Neuropharmacology. 13: S73-80. PMID 2093419 DOI: 10.1097/00002826-199013003-00008  0.676
1990 Lacoste-Royal G, Mathieu M, Nalbantoglu J, Julien JP, Gauthier S, Gauvreau D. Lack of association between two restriction fragment length polymorphisms in the genes for the light and heavy neurofilament proteins and Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 17: 302-5. PMID 1976427 DOI: 10.1017/S0317167100030614  0.349
1989 Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends in Pharmacological Sciences. 80-4. PMID 2694529  0.662
1989 Gauthier S, Bouchard R, Bacher Y, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D. Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 16: 543-6. PMID 2680009 DOI: 10.1017/S0317167100029899  0.423
1989 Gautrin D, Gauthier S. Alzheimer's disease: environmental factors and etiologic hypotheses. Canadian Journal of Neurological Sciences. 16: 375-387. PMID 2680002 DOI: 10.1017/S0317167100029425  0.307
1989 Vida S, Gauthier L, Gauthier S. Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood. The Canadian Journal of Psychiatry. 34: 165-170. PMID 2655861 DOI: 10.1177/070674378903400301  0.382
1988 Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Journal of Neurochemistry. 50: 1914-23. PMID 3373218 DOI: 10.1111/J.1471-4159.1988.Tb02497.X  0.488
1988 Leblanc R, Gauthier S, Gauvin M, Quirion R, Palmour R, Masson H. Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates. Neurology. 38: 1887-90. PMID 2904131 DOI: 10.1212/Wnl.38.12.1887  0.48
1987 Gauthier L, Dalziel S, Gauthier S. The benefits of group occupational therapy for patients with Parkinson's disease. American Journal of Occupational Therapy. 41: 360-365. PMID 3688150 DOI: 10.5014/Ajot.41.6.360  0.303
1987 Quirion R, Welner S, Gauthier S, Bédard P. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Synapse. 1: 559-566. PMID 2843996 DOI: 10.1002/Syn.890010608  0.422
1987 Pilapil C, Welner S, Magnan J, Gauthier S, Quirion R. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain Brain Research Bulletin. 19: 611-615. PMID 2825931 DOI: 10.1016/0361-9230(87)90080-3  0.409
1986 Etienne P, Robitaille Y, Gauthier S, Nair NP. Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease. Canadian Journal of Physiology and Pharmacology. 64: 318-24. PMID 3708439 DOI: 10.1139/Y86-052  0.344
1986 Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NP, Gauthier S. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 503-10. PMID 2878714 DOI: 10.1017/S0317167100037215  0.478
1986 Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 394-402. PMID 2878712 DOI: 10.1017/S0317167100036969  0.51
1983 Wood PL, Etienne P, Lal S, Nair NP, Finlayson MH, Gauthier S, Palo J, Haltia M, Paetau A, Bird ED. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. Journal of the Neurological Sciences. 62: 211-7. PMID 6142096 DOI: 10.1016/0022-510X(83)90200-9  0.438
1983 Wood PL, Nair NP, Etienne P, Lal S, Gauthier S, Robitaille Y, Bird ED, Palo J, Haltia M, Paetau A. Lack of cholinergic deficit in the neocortex in Pick's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 725-7. PMID 6141615 DOI: 10.1016/0278-5846(83)90053-2  0.421
1981 Etienne P, Dastoor D, Gauthier S, Ludwick R, Collier B. Alzheimer disease: Lack of effect of lecithin treatment for 3 months Neurology. 31: 1552-1554. PMID 7198209 DOI: 10.1212/Wnl.31.12.1552  0.326
1978 Etienne P, Gauthier S, Dastoor D, Collier B, Ratner J. Lecithin in Alzheimer's disease. The Lancet. 312: 1206. PMID 82173 DOI: 10.1016/S0140-6736(78)92191-8  0.407
Low-probability matches (unlikely to be authored by this person)
1988 Gauthier S, Gauthier L. Current status of levodopa therapy in idiopathic Parkinson's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 14: 452-4. PMID 3676919 DOI: 10.1017/S0317167100037902  0.3
2003 Feldman H, Levy AR, Hsiung GY, Peters KR, Donald A, Black SE, Bouchard RW, Gauthier SG, Guzman DA, Hogan DB, Kertesz A, Rockwood K. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology. 22: 265-74. PMID 12902621 DOI: 10.1159/000071189  0.298
2006 Gauthier S, Cooper J, Loft H. P2-418: Specific benefits of memantine on behavioural symptoms in patients with moderate to severe Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1259  0.298
1993 Petit D, Montplaisir J, Lorrain D, Gauthier S. THA does not affect sleep or EEG spectral power in Alzheimer's disease. Biological Psychiatry. 33: 753-4. PMID 8353172 DOI: 10.1016/0006-3223(93)90128-Z  0.298
2020 Corriveau-Lecavalier N, Duchesne S, Gauthier S, Hudon C, Kergoat MJ, Mellah S, Belleville S. A quadratic function of activation in individuals at risk of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12139. PMID 33521234 DOI: 10.1002/dad2.12139  0.298
2016 Ismail Z, Brodaty H, Cieslak A, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctot KL, Miller D, Mortby ME, Onyike C, Ortiz LA, Rosenberg P, Smith EE, et al. The Mild Behavioral Impairment Checklist (Mbi-C): A New Rating Scale For Neuropsychiatric Symptoms As Early Manifestations Of Neurodegenerative Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.366  0.298
1998 Gauthier S, Panisset M. Current diagnostic methods and outcome variables for clinical investigation of Alzheimer's disease Journal of Neural Transmission, Supplement. 251-254. PMID 9700662 DOI: 10.1007/978-3-7091-6467-9_22  0.297
2015 Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. International Psychogeriatrics / Ipa. 27: 7-17. PMID 25311499 DOI: 10.1017/S1041610214001963  0.297
2021 Pascoal TA, Benedet AL, Tudorascu DL, Therriault J, Mathotaarachchi S, Savard M, Lussier FZ, Tissot C, Chamoun M, Kang MS, Stevenson J, Massarweh G, Guiot MC, Soucy JP, Gauthier S, et al. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages. Brain : a Journal of Neurology. PMID 34515754 DOI: 10.1093/brain/awab248  0.297
2022 Ashton NJ, Benedet AL, Pascoal TA, Karikari TK, Lantero-Rodriguez J, Brum WS, Mathotaarachchi S, Therriault J, Savard M, Chamoun M, Stoops E, Francois C, Vanmechelen E, Gauthier S, Zimmer ER, et al. Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease. Ebiomedicine. 76: 103836. PMID 35158308 DOI: 10.1016/j.ebiom.2022.103836  0.296
2012 Rainville C, Lepage E, Gauthier S, Kergoat MJ, Belleville S. Executive function deficits in persons with mild cognitive impairment: a study with a Tower of London task. Journal of Clinical and Experimental Neuropsychology. 34: 306-24. PMID 22235943 DOI: 10.1080/13803395.2011.639298  0.296
2022 Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P. Staging of Alzheimer's disease: past, present, and future perspectives. Trends in Molecular Medicine. PMID 35717526 DOI: 10.1016/j.molmed.2022.05.008  0.296
2020 van den Brink SEM, El Amrani L, Therriault J, Gauthier S, Rosa-Neto P, Vitali P. Diagnostic Impact of Cerebrospinal Fluid Biomarkers in Atypical Dementias in Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-29. PMID 32892784 DOI: 10.1017/Cjn.2020.196  0.295
2012 Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP. 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: S1-8. PMID 23073396 DOI: 10.1017/S0317167100015183  0.294
2007 Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/Mds.21507  0.294
2021 Ng KP, Cheng GH, Yatawara C, Rosa-Neto P, Gauthier S, Kandiah N. Baseline Neurodegeneration Influences the Longitudinal Effects of Tau on Cognition. Journal of Alzheimer's Disease : Jad. PMID 33998536 DOI: 10.3233/JAD-201425  0.294
2012 Gauthier S. Management of Alzheimer’s disease using disease-modifying drugs Neurodegenerative Disease Management. 2: 375-378. DOI: 10.2217/Nmt.12.37  0.293
1991 Poirier J, Kogan S, Gauthier S. Environment, Genetics and Idiopathic Parkinson's Disease Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 18: 70-76. DOI: 10.1017/S0317167100031334  0.293
2018 Corriveau-Lecavalier N, Rajah N, Duchesne S, Gauthier S, Benali H, Mellah S, Belleville S. P3-372: Presence Of Task-Related Hyperactivation In Persons With Subjective Cognitive Decline: Evidence From The Cima-Q Cohort Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1734  0.293
2016 Reisberg B, Torossian C, Shulman M, Monteiro I, Gauthier S, Shao Y. F1-04-02: Global Deterioration Scale (GDS) Stage 2: Persons with Subjective Cognitive Impairment (SCI) Only Show Significant Declines in GDS Staging System Measures Over a 2-Year Interval Alzheimer's & Dementia. 12: P167-P168. DOI: 10.1016/J.Jalz.2016.06.284  0.292
1996 Bergem ALM, Burns A, Eriksson S, Finkel S, Gauthier S, Levy R, Mallery L. Round Table Discussion: The Clinician's View on Outcome Methodologies for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer's Disease International Psychogeriatrics. 8: 335-342. DOI: 10.1017/S1041610296002694  0.292
2002 Gauthier S. Advances in the pharmacotherapy of Alzheimer's disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 166: 616-23. PMID 11898943  0.292
2023 Tedeschi Dauar M, Pascoal TA, Therriault J, Rowley J, Mohaddes S, Shin M, Zimmer ER, Eskildsen SF, Fonov VS, Gauthier S, Poirier J, Rosa-Neto P. Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer's Disease. Brain Sciences. 13. PMID 36831775 DOI: 10.3390/brainsci13020232  0.291
2022 Cassidy CM, Therriault J, Pascoal TA, Cheung V, Savard M, Tuominen L, Chamoun M, McCall A, Celebi S, Lussier F, Massarweh G, Soucy JP, Weinshenker D, Tardif C, Ismail Z, ... Gauthier S, et al. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35177805 DOI: 10.1038/s41386-022-01293-6  0.29
2006 Touchon J, Portet F, Gauthier S. Prevention trials in Alzheimer disease: one step forward? Neurology. 67: S21-2. PMID 17101931  0.29
2021 Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, ... ... Gauthier S, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8  0.29
2021 Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, ... ... Gauthier S, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8  0.29
2021 Tissot C, Therriault J, Pascoal TA, Chamoun M, Lussier FZ, Savard M, Mathotaarachchi SS, L Benedet A, Thomas EM, Parsons M, Nasreddine Z, Rosa-Neto P, Gauthier S. Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12154. PMID 33816761 DOI: 10.1002/trc2.12154  0.289
2016 Zimmer ER, Parent MJ, Shin M, Kang MS, Aliaga A, Carmo SD, Gauthier S, Cuello AC, Rosa-Neto P. AMYLOID-BETA 1-42 (Aβ1-42) LEVELS IN THE CEREBROSPINAL FLUID ASSOCIATE WITH SPATIAL MEMORY PERFORMANCE IN AGED BUT NOT IN ADULT MCGILL-R-THY1-APP RATS Alzheimers & Dementia. 12: 440. DOI: 10.1016/J.Jalz.2016.06.849  0.289
1992 Baumgarten M, Battista RN, Infante-Rivard C, Hanley JA, Becker R, Gauthier S. The psychological and physical health of family members caring for an elderly person with dementia. Journal of Clinical Epidemiology. 45: 61-70. PMID 1738013 DOI: 10.1016/0895-4356(92)90189-T  0.288
2018 Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Shi L, Gong M, Xu H, Li F, He J, Song H, Yang S, Zhou A, Wang F, ... ... Gauthier S, et al. Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial. Alzheimer's & Dementia (New York, N. Y.). 4: 108-117. PMID 29955654 DOI: 10.1016/J.Trci.2018.02.004  0.288
2020 Therriault J, Pascoal TA, Savard M, Benedet AL, Chamoun M, Tissot C, Lussier F, Kang MS, Thomas E, Terada T, Rej S, Massarweh G, Nasreddine Z, Vitali P, Soucy JP, ... ... Gauthier S, et al. Topographical distribution of amyloid-β, tau and atrophy in behavioral / dysexecutive AD patients. Neurology. PMID 33093220 DOI: 10.1212/WNL.0000000000011081  0.287
2020 Smith EE, Barber P, Field TS, Ganesh A, Hachinski V, Hogan DB, Lanctôt KL, Lindsay MP, Sharma M, Swartz RH, Ismail Z, Gauthier S, Black SE. Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment. Alzheimer's & Dementia (New York, N. Y.). 6: e12056. PMID 33209971 DOI: 10.1002/trc2.12056  0.287
2017 Aghourian M, Legault-Denis C, Soucy JP, Rosa-Neto P, Gauthier S, Kostikov A, Gravel P, Bédard MA. Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [(18)F]-FEOBV. Molecular Psychiatry. PMID 28894304 DOI: 10.1038/mp.2017.183  0.286
2023 Guilliot S, Gauthier S, Touchon J, Soto ME. Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives. Journal of Alzheimer's Disease : Jad. PMID 37781804 DOI: 10.3233/JAD-230568  0.286
2012 Peters F, Ergis AM, Gauthier S, Dieudonné B, Verny M, Jolicoeur P, Belleville S. Abnormal temporal dynamics of visual attention in Alzheimer's disease and in dementia with Lewy bodies. Neurobiology of Aging. 33: 1012.e1-10. PMID 22130206 DOI: 10.1016/J.Neurobiolaging.2011.10.019  0.285
2022 Iturria-Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa-Neto P, O'Donnell K, Petyuk VA, Gauthier S, De Jager PL, Breitner J, Bennett DA. Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity. Science Advances. 8: eabo6764. PMID 36399579 DOI: 10.1126/sciadv.abo6764  0.285
1996 Liu L, Gauthier L, Gauthier S. Personal and Extrapersonal Orientation in Persons with Alzheimer Disease: Reliability and Validity of Three Assessments Canadian Journal of Occupational Therapy. 63: 162-172. DOI: 10.1177/000841749606300303  0.285
2014 Cheewakriengkrai L, Manitsirikul S, Mohades S, Wang S, Shin M, Benedet AL, Leuzy A, Parent M, Zimmer ER, Kang MS, Schilling LP, Farajat D, Fonov V, Beaudry T, Mathotaarachchi S, ... Gauthier S, et al. Neurodegeneration Associated With Longitudinal Changes Of Ab1-42 And Fibrillary Amyloid Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.145  0.285
2003 O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. The Lancet. Neurology. 2: 89-98. PMID 12849265 DOI: 10.1016/S1474-4422(03)00305-3  0.284
2009 Gauthier S, Touchon J, Vellas B, Katchaturian Z. CTAD international research conference: Clinical trials in Alzheimer’s disease The Journal of Nutrition, Health and Aging. 13: 204-204. DOI: 10.1007/S12603-009-0058-1  0.284
2013 Cheewakriengkrai L, Rowley J, Mohades S, Beaudry T, Leuzy A, Zimmer E, Fonov V, Gauthier S, Rosa-Neto P. Regional distribution of fibrillar amyloid deposition in the brain as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.012  0.283
2013 Cheewakriengkrai L, Rowley J, Mohades S, Beaudry T, Leuzy A, Zimmer E, Fonov V, Gauthier S, Rosa-Neto P. Regional distribution of brain fibrillar amyloid deposition as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.477  0.283
2022 Ferrari-Souza JP, Ferreira PCL, Bellaver B, Tissot C, Wang YT, Leffa DT, Brum WS, Benedet AL, Ashton NJ, De Bastiani MA, Rocha A, Therriault J, Lussier FZ, Chamoun M, Servaes S, ... ... Gauthier S, et al. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease. Molecular Psychiatry. PMID 35948658 DOI: 10.1038/s41380-022-01716-2  0.283
2005 Vellas B, Gauthier S, Allain H, Andrieu S, Aquino JP, Berrut G, Berthel M, Blanchard F, Camus V, Dartigues JF, Dubois B, Forette F, Franco A, Gonthier R, Grand A, et al. [Consensus statement on severe dementia]. Presse Mã©Dicale (Paris, France : 1983). 34: 1545-55. PMID 16301969 DOI: 10.1016/S0755-4982(05)84221-6  0.283
1994 Baumgarten M, Hanley JA, Infante-Rivard C, Battista RN, Becker R, Gauthier S. Health of family members caring for elderly persons with dementia: A longitudinal study Annals of Internal Medicine. 120: 126-132. PMID 8256971 DOI: 10.7326/0003-4819-120-2-199401150-00005  0.283
2018 Ng KP, Richard-Devantoy S, Bertrand J, Jiang L, Pascoal TA, Mathotaarachchi S, Therriault J, Yatawara C, Kandiah N, Greenwood CMT, Rosa-Neto P, Gauthier S. P1-342: Suicidal Ideation Is Prevalent In Both Asymptomatic Autosomal Dominant Alzheimer'S Disease Mutation And Non-Mutation Carriers Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.349  0.282
2018 Savard M, Mathotaarachchi S, Kang MS, Pascoal TA, Therriault J, Benedet AL, Chamoun M, Thomas EM, Gauthier S, Rosa-Neto P. P3-096: The Synergistic Interaction Between Amyloid And Tau Disrupts Local And Global Resting State Fmri Connectivity Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1452  0.282
1995 Keyserlingk EW, Glass K, Kogan S, Gauthier S. Proposed guidelines for the participation of persons with dementia as research subjects. Perspectives in Biology and Medicine. 38: 317-362. DOI: 10.1353/Pbm.1995.0049  0.282
2004 McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, et al. Dementia with Lewy bodies. The Lancet. Neurology. 3: 19-28. PMID 14693108 DOI: 10.1016/S1474-4422(03)00619-7  0.281
2024 Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nature Reviews. Neurology. PMID 38429551 DOI: 10.1038/s41582-024-00942-2  0.281
2007 Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/Mds.21844  0.281
2021 Xu L, Li T, Xiong L, Wang X, Ismail Z, Fukuda M, Sun Z, Wang J, Gauthier S, Yu X, Wang H. Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33935092 DOI: 10.3233/JAD-210098  0.279
2023 Pascoal T, Bellaver B, Povala G, Ferreira P, Ferrari-Souza JP, Leffa D, Lussier F, Benedet A, Ashton N, Triana-Baltzerz G, Kolbzh H, Tissot C, Therriault J, Servaes S, Stevenson J, ... ... Gauthier S, et al. Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's disease. Research Square. PMID 36778243 DOI: 10.21203/rs.3.rs-2507179/v1  0.279
2021 Therriault J, Benedet AL, Pascoal TA, Lussier FZ, Tissot C, Karikari TK, Ashton NJ, Chamoun M, Bezgin G, Mathotaarachchi S, Gauthier S, Saha-Chaudhuri P, Zetterberg H, Blennow K, Rosa-Neto P, et al. Association of plasma P-tau181 with memory decline in non-demented adults. Brain Communications. 3: fcab136. PMID 34222875 DOI: 10.1093/braincomms/fcab136  0.279
2021 Therriault J, Benedet AL, Pascoal TA, Lussier FZ, Tissot C, Karikari TK, Ashton NJ, Chamoun M, Bezgin G, Mathotaarachchi S, Gauthier S, Saha-Chaudhuri P, Zetterberg H, Blennow K, Rosa-Neto P, et al. Association of plasma P-tau181 with memory decline in non-demented adults. Brain Communications. 3: fcab136. PMID 34222875 DOI: 10.1093/braincomms/fcab136  0.279
2021 Tremblay-Mercier J, Madjar C, Das S, Pichet Binette A, Dyke SOM, Étienne P, Lafaille-Magnan ME, Remz J, Bellec P, Louis Collins D, Natasha Rajah M, Bohbot V, Leoutsakos JM, Iturria-Medina Y, Kat J, ... ... Gauthier S, et al. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease. Neuroimage. Clinical. 31: 102733. PMID 34192666 DOI: 10.1016/j.nicl.2021.102733  0.278
2015 Wajman JR, Bertolucci PHF, Mansur LL, Gauthier S. Culture as a variable in neuroscience and clinical neuropsychology: A comprehensive review. Dementia & Neuropsychologia. 9: 203-218. PMID 29213964 DOI: 10.1590/1980-57642015Dn93000002  0.278
Hide low-probability matches.